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Summary (English)
Understanding the link between the human gut microbiome and human health is
one of the biggest scientific challenges in our decade. Because 90% of our cells are
bacteria, and the microbial genome contains 200 times more genes than the human
genome, the study of the human microbiome has the potential to impact many areas
of our health. This PhD thesis is the first study to generate a large amount of exper-
imental data on the DNA and RNA of the human gut microbiome. This was made
possible by our development of a human gut microbiome array capable of profiling
any human gut microbiome. Analysis of our results changes the way we link the gut
microbiome with diseases. Our results indicate that inflammatory diseases will affect
the ecological system of the human gut microbiome, reducing its diversity. Classi-
fication analysis of healthy and unhealthy individuals demonstrates that unhealthy
individuals have lower diversity microbiomes with incomplete functional capacity.
Diversity is an important measurement linking microbiome variance to diseases. Our
results suggest that diseases are linked to the microbiome not by the presence of
“bad” bacteria, but mostly by the loss of the “good” bacteria. Finally, we show that
bacterial adaptations explain the shift observed in the human gut microbiome.
ii
Summary (Danish)
At forstå betydningen af den mikrobielle flora i menneskets tarmsystem i sammen-
hæng med vores sundhed, er et af de største videnskabelige udfordringer i vores årti.
Da 90% af vores celler er bakterier, og det mikrobielle genom indeholder 200 gange
flere gener end det humane genom, kan en undersøgelse af den humane mikrobiom
have potentiale til at påvirke mange områder vedrørende vores helbredet. I dette PhD
forløb har vi genereret en stor mængde eksperimentelle data baseret på DNA og RNA
af det humane tarm mikrobiom. Dette blev gjort ved lave en chip for mikrobiomet af
det humane tarmsystem som gør os i stand til at lave en profil af alle mulige humane
mikrobiomer fra tarmsystemet. Analyse af vores resultater ændrer den måde, hvor-
ved vi releterer tarmmikribiomet med sygdomme. Vore resultater viser, at en human
sygdom vil påvirke det økologiske system af det humane tarm mikrobiom og reduce-
rer diversiteten af mikrofloraen. En undersøgelse af sunde og usunde individer viser,
at usunde individer har lavere mangfoldighed i deres mikrobiom og en ufuldstændig
funktionel kapacitet. Mangfoldighed er en vigtig parameter, som relaterer variansen
af et mikrobiom med bestemte sygdomme. Vore resultater viser at sygdomme er for-
bundet til mikribiomet; ikke ved tilstedeværelsen af ‘dårlige’ bakterier, men især ved
tabet af ‘gode’ bakterier. Endelig viser vi, at bakterielle tilpasninger kan forklare skift
observeret i det menneskelige tarm mikrobiom.
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Chapter 1
Introduction
Metagenomics is a new technique developed to study genomes directly in their nat-
ural environments. As with many techniques, metagenomics has evolved with other
technologies, and it currently has a broad spectrum of applications. It is an important
tool for academic research and industry, facilitating the identification of new species
and enzymes. Moreover, metagenomics is elucidating the organization of microbial
communities and the mechanisms through which species interact with one another.
This introduction is a discussion of the development and use of metagenomics and its
benefits for academic research and industry. A good example of its application in the
food industry is the launch of Activia, a brand of yogurt containing a specific pro-
biotic bacterium. Developed by Danone, a multinational food products corporation,
Activia became one of the most successful product launches in recent history. The
Metagenomics of the Human Intestinal Tract (MetaHIT) project and the objectives
of this thesis are also described in this section.
1.1 Metagenomics and sequencing technologies
Major breakthroughs in science frequently follow the development of new investiga-
tive methods. The development of microscopes in the 17th century ushered in the
discovery of bacteria, changing the treatment of diseases and the approach to human
interactions with microorganisms. In the 20th century, the development of X-ray
diffraction techniques paved the way for the discovery of the structure of DNA. Al-
though these two techniques were not developed with the intention of increasing
biological knowledge, they made significant contributions to the field nonetheless.
Metagenomics is a new technique developed to overcome several limitations of ge-
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nomic studies. It enables researchers to sequence genomes that were previously in-
accessible, thereby providing important insights into community genomic studies.
However, the advancement of metagenomics has been made possible only by im-
provements in sequencing techniques. The structure of DNA was discovered in 1953
[1], but DNA sequencing technologies did not emerge until two decades later. Many
sequencing techniques were developed in the early 1970s [2, 3]. However, the chain-
termination method — developed by Frederick Sanger and co-workers in 1977 [4]
— became the method of choice owing to its relative ease and reliability. Improve-
ments in robotics, reagents, and computer software increased the efficiency of this
method, and in 2001, it was applied to the human genome. Capillary electrophoresis
instruments were developed that could detect 500–600 base pairs per reaction from
individual fluorescently labelled samples in 10 hours. These machines were capable
of performing 96 reactions per run, sequencing 115 kilobases in 24 hours of non-stop
operation [5]. To put this output in perspective, approximately 4% of the Escherichia
coli genome or 0.003% of the human genome could be sequenced per day. In 2005, a
range of DNA sequencing techniques that were fundamentally different from capillary
sequencing became available from several manufacturers (Figure 1.1). These new or
‘next-generation’ sequencing (NGS) technologies can be divided into four categories:
emulsion polymerase chain reaction (Roche/454, Life/APG, Polonator), solid-phase
amplification (Illumina/Solexa), single molecule: primer immobilised (Helicos Bio-
Sciences), and polymerase immobilised (Pacific Biosciences, Life/Visigen, LI-COR
Biosciences). Compared with their predecessors, these new sequencing machines are
superior by several orders of magnitude (0.45–50 gigabases per run). The basic mech-
anisms for data generation with the new instruments changed drastically, producing
more sequence reads per instrument run at a significantly lower expense. Competi-
tion among different manufactures has decreased the cost of the sequencing machines
and also democratised sequencing technology [5].
The high amount of data produced and the low cost of operating the new technolo-
gies enable the profiling of multiple species simultaneously, thereby improving in situ
analysis. Biologists have performed experimental analyses in vivo for a long time,
in which a controlled environment permits the observation of a single stress factor
in an organism. However, most microorganisms do not exist alone in nature, and
their behaviour is influenced by many environmental factors. Thus, an improved un-
derstanding of the biology of an organism may be gained by studying the organism
within its own environment. Improvements in sequencing have allowed biologists to
collect large amounts of data from in situ experiments. The term ‘metagenomics’ first
appeared in 1998 [6] to establish the idea that genes from uncultivable microorgan-
ism could be analysed directly from the environment in ways similar to those applied
to the study of a single genome. An increasing interest in environmental genetics
resulted in the broader use of the term metagenomics to describe the sequencing of
any genetic material from environmental samples (Figure 1.2). Recently, Kevin Chen
and Lior Pachter [7] defined metagenomics as “the application of modern genomics
techniques to the study of communities of microbial organisms directly in their nat-
ural environments, by-passing the need for isolation and laboratory cultivation of
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Figure 1.1: Figure 1 from perspective article [5] aggregating facts, which are im-
portant to understanding the impact of sequencing technology in biological research.
The timeline shows how recently the new sequencing machines were introduced. Out-
put increased exponentially between 2003 and 2006 and solved problems that would
have been unthinkable to researchers just a decade ago.
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individual species”.
The earth is a repository of resources that are important for human health and in-
dustry and provide food, clean air and water, shelter, and fuel. However, the vast
number of resources available has not been fully explored. The total number of living
organisms on the planet is currently unknown but is estimated to be more than 1030
bacteria alone [8]. Prokaryotes are thought to be the first organisms that evolved on
Earth, appearing 3.5 billion years ago. Since then, these organisms have occupied the
most extreme niches — from nuclear power plants to the human gut — by developing
tools to survive and adapt to a wide variety of environments. Bacteria have frequently
played an important role in life and industry; however, less than 1% of bacteria have
been taxonomically classified, and only a few species (e.g. model organisms) have
been physiologically characterised. Nevertheless, many important bacterial enzymes
and antibiotics have been identified and are currently in used in health and indus-
trial sectors. The potential for metagenomics applications in industry are many, and
they are still in their infancy. In 2003, sales of industrial enzymes were estimated
at $2.3 billion [9], with the top four being detergents ($789 million), food applica-
tions ($634 million), agriculture/feed ($376 million), and textile processing ($237
million) [10]. The use of metagenomics and biotechnology has advantages over the
industrial processes currently in use. Microorganisms are already producing many
interesting industrial compounds, so the main challenge lies in developing large-scale
processes. Large-scale biotechnology can replace or complement traditional indus-
trial production, especially in chemical industries. The potential for biotechnology
to replace traditional methods is enormous. For instance, biotechnology can produce
an estimated 10–20% of all chemicals sold, with a market value of $160 billion. The
percentage of intermediary products within reach with biotechnology is up to 60%
and covers a large range of products (e.g. detergents, agro-chemicals, and pharma-
ceuticals) [10]. Moreover, biocatalysis can introduce superior synthetic strategies in
10% of these processes, surpassing the effectiveness of classical chemical reactions
[11].
Metagenomics may be a key factor in the identification of new enzymes to boost
biotechnology. The metagenomics era began when sequencing was still expensive.
Thus, before genomes from the whole environment could be sequenced, fragments of
DNA had to be cloned into a host (e.g. E. coli), and the clones were screened for
the enzyme of interest. After screening the clone for the target enzyme, the clone
was isolated, extracted from the host, and completely sequenced. After assembly,
bioinformaticians conducted a search for the enzyme in the cloned fragment. How-
ever, thousands or millions of genes may be present in some environments, many
of which have biotechnological potential. Reductions in sequencing costs have en-
abled researchers to sequence multiple genes without cloning. Thus, metagenomics
removes the cloning and screening steps, thereby speeding up the sequencing process
and increasing the number of genes that can be analysed
Metagenomics has the potential to reveal the immense uncultured microbial diversity
present in the environment and offer new molecules for biotechnological and ther-
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Figure 1.2: Figure 3 from article [6] showing the extraction of genomic information
from unknown soil organisms. This technique symbolises the beginning of metage-
nomic studies, and the report on this technique was the first to use the term metage-
nomics and describe the methodology.
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apeutic applications. It can also be used to identify the species are present in an
environment through 16S ribosomal RNA (rRNA) sequencing, highlight differences
in bacterial communities, and evaluate the impact of external variables on a bacterial
community — e.g. drugs, food, or bacterial species. These capabilities are partic-
ularly important when studying the association of the microbiome — a community
of microbes within a given environment — with disease. Early examples of metage-
nomic applications include the analysis of previously sampled environments, such as
the ocean [12, 13, 14], an acid mine site [15], soil [16, 17], and coral reefs [18]. However,
these studies were limited by expensive sequencing processes incapable of revealing
complex diversity. By contrast, NGS platforms, which provide fast, low-cost, and
data-intensive output, have increased the application of metagenomic studies.
The human body contains a high number of ecosystems that are colonised by a di-
verse number of microorganisms, including the gastrointestinal tract, vagina, skin,
and oral and nasal cavities. Variations in the microbial community of these ecosys-
tems may be related to the health status of an individual. The humans gut has been
extensively studied, through 16S rRNA classification, capillary electrophoresis and
454 pyrosequencing [19, 20, 21, 22, 23, 24, 25]. The International Human Project is
a large-scale endeavour aiming to develop a set of reference genomes from the human
microbiome by sequencing hundreds of cultured and uncultured microbial genomes
found in the human gut. The apparent relationship between human bodies and their
microbiota communities combined with improvements offered by NGS technologies
have opened the door for investigations of the interconnections among microbial pop-
ulations and health status. This unique opportunity is being explored by two major
projects, the Human Microbiome Initiative in the United States and MetaHIT in
Europe. The MetaHIT study has the potential to enhance current knowledge about
bacterial interactions with their hosts and with one another. The analysis of bacte-
rial sub-products may help to reveal how the human microbiome influences human
health. For example, the International Human Microbiome Consortium (IHMC),
which includes MetaHIT, may provide information on the effects of probiotics and
prebiotics in the human gut microbiome, thereby aiding the food industry. More-
over, the data produced by the consortium could be used to create tools to facilitate
studies of the human microbiome.
The food industry is responding to consumer interest in healthier eating by produc-
ing new products. Probiotics are an important aspect of this initiative, and some
companies are already using ‘bugs to create bucks’. In 2005, Danone launched a
series of products containing the probiotic strain Bifidobacterium animalis DN173
010. This probiotic is the key ingredient in Activia, a yogurt marketed as an aid
for constipation (Figure 1.3). Activia posted nearly $2 billion in worldwide sales
in 2006, an increase of 30% over previous sales. Analysts have reported that the
introduction of Activia in the United States in 2006 through the company’s Dannon
division was one of the most successful product launches in the recent history of the
food industry, with sales of $300 million in 2007. Until recently, most of the bacteria
in the human gut — including B. animalis DN173010, which has been shown to help
ease constipation — had not been fully analysed. However, the capability of modern
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Figure 1.3: Activia an example of a probiotic product. Activia was recently de-
veloped by Danone (known as Dannon in the United States) to fulfil the demand
by consumers for healthier products. Activia is classified as functional food, and
the company claims that it benefits human health by improving intestinal motility.
The yogurt contains Bifidobacterium animalis DN 173 010, which bears the trade
names Bifidobacterium Lactis, Bifidus Digestivum, Bifidus Actiregularis, and Bifidus
Regularis.
sequencing techniques to map bacterial DNA in few days has expanded the explo-
ration of gut flora. Company communications from Danone insist that, “The more
we look, the more we are finding health benefit” [26]. Lactobacillus casei DN-114001,
for example, appeared to boost the immune system in clinical trials. As a result,
it was added to a yogurt drink introduced in the United States in 2007 under the
brand name DanActive [26]. These products highlight the importance of human gut
microbiome research and its applications in industry.
1.2 MetaHIT: the project objectives
MetaHIT was a project financed by the European Commission under the Seventh
Framework Programme. It includes 13 academia and industry partners from eight
countries. The total cost of MetaHIT has been evaluated at more than 21.2 million
euros, and the funding requested from the European Commission had an upper limit
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of 11.4 million euros. The project started in January 2008 and ended in June 2012.
The central goal of the MetaHIT project is to find associations among the genes
of the human intestinal microbiota and human health, especially as they pertain to
inflammatory bowel disease (IBD) and obesity, disorders of growing importance in
Europe. Cases of IBD have been increasing in recent decades in Western Europe,
and this tendency is now being observed in Eastern Europe as well. Rises in obe-
sity have been reported in many countries, and both diseases present an increasing
challenge for public health services. To reach its principal objectives, the MetaHIT
consortium has (1) established an extensive reference catalogue of microbial genes
present in the human intestine, (2) developed bioinformatics tools to store, organise,
and interpret this information, (3) determined the genes carried by cohorts of sick
and healthy individuals, and (4) devised methods to study the function of bacterial
genes associated with disease with the aim of understanding their underlying mech-
anisms and host–microbe interactions. To integrate this project into the real world,
the MetaHIT consortium actively participates in the IHMC, transfers technology to
industry, and presents information about the project to the general public.
1.3 Thesis objectives
The main objective of this thesis was to advance understanding of how the human
gut microbiome affects health. However, to reach such a goal, we needed to create
new tools and software to handle and analyse data from metagenomics, NGS, and
metagenome arrays. During the period described herein, I developed a new tool
to process empirical data on the human gut microbiome. As a result, I created
the first human gut microbiome microarray, which generated DNA abundance and
RNA expression data. This ‘Gut-Array’ includes 840,000 genes from more than
250 bacterial species commonly found in the human gut, and the results have been
presented in the published scientific papers highlighted in this thesis. To design the
microarray, I developed software to handle probe design for multiple species. This
software, Meta-OligoWiz, is based on OligoWiz [27], which designs microarrays for
single species.
Data analysis is an important component of a thorough exploration of the human
gut microbiome. Therefore, I developed an R-package (MetaHIT-R) to investigate
how the human gut microbiome affects human health. This thesis focuses on the
scientific results produced by these tools and is composed of three articles. The first
article focuses on the massive amount of empirical data produced by sequencing. The
second article discusses data analysis, revealing an unexpected trend that could not
be explained in the microbiome data distribution. The third article aims not only
to explain the microbiome data distribution but also to define the constituents of
healthy and unhealthy human gut microbiomes. It has been recently proposed that
ecological theory must be applied to the human gut microbiome [28]. The third article
applies many ecological concepts that have changed the way researchers associate
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the microbiome with disease. This article is the first to apply ecological concepts to
four datasets using three different technologies. One of the goals of MetaHIT is to
find bacteria that are responsible for disease. The idea of ‘good’ and ‘bad’ bacteria
predominated until recently, when studies emerged that moved the perception of
the microbiota–disease relationship in a different direction. The three articles in
this thesis follow a timeline in the MetaHIT project and reveal how awareness of
this relationship changed. The first article provides the data necessary to study
the microbiome. The second demonstrates an unexpected result–that individual
microbiomes can be clustered into three groups, called ‘Enterotypes’. The third uses
ecological theory to explain the clusters and their link with disease. Changing the
way we link the human gut microbiome to our healthy.
10 Introduction
Chapter 2
Background
The most relevant and recent knowledge about the human gut microbiome is dis-
cussed in this section. The biological relevance of the human gut microbiome is also
examined, and the results of recent articles are summarised. Moreover, because the
study of the human gut microbiome is a multidisciplinary field, I introduce concepts
from scientific disciplines other than metagenomics that are central to explanations
of the link between the gut microbiome and disease. These explanations will help
readers from all scientific backgrounds comprehend the results and conclusions in
this thesis. The background is divided into four sections. In the microbiology sec-
tion, taxonomy classification is discussed with a focus on the link between pheno-
type characteristics and functional capacity. The gut microbiome section has three
themes: bacterial composition, shifts observed in diseases, and evolutionary aspects
of human gut microbiome composition that explain its co-evolution with humans.
Another section of the background discusses the factors suggested to influence mi-
crobiome composition, and the final section discusses some of the ecological features
of the human gut microbiome.
2.1 Microbiology
2.1.1 Biological classification
The grouping of living and nonliving things that have similar characteristics is a
common procedure in science. One of the first records of such classification can be
found in the work of the philosopher Aristotle (384 BC – 322 BC) during the fourth
century BC. Aristotle created biological classifications in his ‘Metaphysics’ book in
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which he grouped animals by their characteristics — e.g. animals with blood and
those without Such separations help to reveal the common characteristics of organ-
isms and therefore suggest a common origin for them. Carl Linnaeus (1707 – 1778)
would later divide nature into three kingdoms in which species were grouped accord-
ing to morphology in ‘Systema Naturae’. Linnaeus hypothesised that species with
similar physical characteristics were more likely to be related and should therefore
be placed more closely in a taxonomic rank. This form of classification is still used
today to group species.
Prokaryote classification follows the same idea, applying morphology to define tax-
onomic rank. Rules can be applied to this process and are described in detail in
Bergey’s Manual of Systematic Bacteriology. The overall characteristics include cell
wall type, cell shape, oxygen requirements, endospore production, motility, and glu-
cose fermentation activity, among others. However, some species groups are extraor-
dinarily diverse, and morphological characterization is inadequate to separate them
into subgroups. The advent of NGS technologies allows the use of new characteristics
such as GC content to define similarities and group species. The increased capacity
of modern sequencing machines permit the phylogenetic analysis of 16S rRNA genes,
which can be used to cluster species into taxonomy groups. This methodology has
confirmed many existing groupings, supporting the idea that species, which share
morphology, are likely to have common ancestry. These techniques also provide in-
teresting insights on bacterial evolution. Some groups with distinct morphological
characteristics have been grouped together using 16S rRNA. Aristotle’s ancient bio-
logical classification grouped animals that could fly and animals of the sea. Current
classifications reflect that even though bats and birds can fly, their wings have re-
sulted from independent evolutionary events. The same principle can be applied
to whales and fish. 16S rRNA adds similar evolutionary information to bacterial
classification and is especially important for Clostridium species. Species from order
Clostridiales have been shown to belong to clusters that disagree with the current
scientific classification [29], suggesting that some of these species have different evolu-
tionary origins. Because most of the species from the human gut microbiome belong
to the order Clostridiales, correct taxonomy classification may have a critical impact
on the understanding of their role in disease. In fact, species in the colon belonging
to Clostridium clusters IV and XIVa induce T regulatory cells (Tregs) [30], which are
important to immune homeostasis. Therefore, the use of phylogenetic 16S rRNA can
enhance knowledge of the human gut microbiome. Furthermore, grouping organisms
by characteristics is a valuable technique, which can further understanding of their
function in the human gut microbiome.
2.1.2 Bacterial phenotype
Current biological classification is mostly based on morphology and biochemistry.
The idea that species with shared characteristics are likely to have common ancestry
is supported by 16S rRNA phylogenetic analysis. Therefore, organisms with simi-
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lar phenotypes are likely to perform related functions or occupy analogous niches.
Phylogeny classification of organisms in the human gut microbiome can help reveal
conserved morphology and elucidate functional capacity, providing insights on the
possible link between the microbiome and disease. Herein I discuss the morphological
characteristics of the human gut microbiome relevant to this thesis.
In the late 19th century, Hans Christian Gram (1850–1938), a Danish scientist, in-
vented a technique for identifying the presence of peptidoglycan in the bacterial
envelope. The technique uses hexamethyl pararosaniline chloride dye, which is re-
tained by peptidoglycan. Thus, high levels of peptidoglycan produce a dark violet
colour and low levels result in red/pink colours. Today most bacteria can be divided
into two groups by the composition of peptidoglycan in the cell wall. Gram-positive
bacteria have large amounts of peptidoglycan (50-90%) and Gram-negative bacteria
have small amounts (10%). Gram-positive and Gram-negative bacteria have other
differences as well. The Gram-negative cell wall is characterised by the presence
of lipopolysaccharide (LPS). LPS is composed of lipids and polysaccharides and is
located at the outer membrane. It acts as an endotoxin in animals and activates a
strong immune response. However, LPSs display diverse levels of toxicity. LPSs from
Bacteroides are reportedly 10 to 5,000 times less toxic than hose from E. coli [31],
indicating that Gram-negative bacteria affect their hosts in different ways.
Bacteria are also often classified by their capacity to use or survive in oxygen. Fig-
ure 2.1 depicts a classification of bacteria based on their behaviour in the presence of
oxygen. In general, bacteria are grouped by their capacity to produce energy using
oxygen. Those that can do so are classified as aerobes, and those that cannot are
anaerobes. However, some microorganisms, classified as facultative, can generate
energy with or without oxygen. In the presence of oxygen, they produce ATP via
aerobic respiration, and without it, they produce energy via fermentation. Staphy-
lococcus and E. coli are examples of facultative bacteria in the gut. Although some
bacteria cannot produce energy from oxygen, they can tolerate its presence and are
classified as aerotolerant. Bacteroides and Lactobacillus are aerotolerant species. Be-
cause the human gut is an anaerobic environment, the composition of the microbiome
is dominated by anaerobic bacteria. However, increases in oxygen occasionally occur
in the human gut—e.g. in cases of damage to the gut wall or inflammatory responses
by reactive oxygen species (ROS) [32, 33]. Oxygen in the gut kills strict anaerobic
bacteria and increases the abundance of species that tolerate or produce energy from
oxygen.
2.1.3 Bacterial fermentation: short-chain fatty acids
Short-chain fatty acids (SCFAs) are products of bacterial fermentation under anaer-
obic conditions. SCFAs are classified as fatty acids with less than six carbons and
aliphatic tails. Three SCFAs are integral for human health: acetate (with two car-
bons), propionate (with three carbons), and butyrate (with four carbons). SCFAs
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Figure 2.1: Figure from Wikipedia [34]. Bacteroides species are consistently classi-
fied as strictly anaerobic, but they have demonstrated a capacity to tolerate oxygen.
[35, 36]. Strict aerobic bacteria group close to the top of test tube (1), whereas strict
anaerobes group at the bottom (2). Facultative bacteria (3) are more concentrated
at the top because they are more energy efficient. Microaerophiles (4) require lower
levels of oxygen (around 20%) to survive. Aerotolerant bacteria (5) do not use oxygen
to produce energy but can tolerate its presence.
in the human intestine are used by the epithelial cells of the colon (colonocytes) as
energy sources [37], and an estimated 5-10% of basal energy in humans is provided
by SCFAs [38]. In addition to their roles as energy sources, SCFAs are involved in
diverse processes related to the immune system [37]. SCFAs have been shown to ac-
tivate inflammatory responses [39]. They induce apoptosis in lymphocytes [40, 41],
neutrophils [42], and macrophages [43] and affect leukocytes. The role of SCFAs
in apoptosis is not well understood but may be relevant to inflammatory response.
Butyrate reduces the phagocytic activity of macrophages [44]. Thus, in general, SC-
FAs, especially butyrate [45], are considered to have anti-inflammatory action [46].
Because SCFAs are products of fermentation, the presence of oxygen in the gut may
reduce their production.
2.2 Relevance of the gut microbiome
This section describes the importance of studying the gut microbiome and the ways
in which it can influence human health. The most well-characterised effects of the gut
microbiome on the host include energy absorption from food, production of vitamins,
defence against pathogens, and interference with the immune system. Individual di-
gestive capacity depends on microbiome composition [20, 22, 23, 47]. Mice with a
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high relative abundance of Firmicutes have an increased capacity to extract energy
from food [23], and mice given diets that restrict carbohydrates or fats display an in-
creased abundance of Bacteroidetes [48]. Microbiota metabolism of oxalate has been
linked to a predisposition for kidney stones [49], and lipid metabolism is affected by
microorganisms, which modify bile acids [50]. Interactions between the microbiota
and immune cells have a demonstrably important impact in their host. Gut epithelial
cells renew more slowly in germ-free mice than in colonised mice [51]. The presence
of the microbiome can influence abnormal cell proliferation (neoplasia) [52] and alter
the capacity of cells to repair damaged mucosal barriers [51]. In addition, the suscep-
tibility of the gut to colonisation by enteropathogens is affected by the capacity of the
microbiota to alter the expression of host genes encoding anti-microbial compounds
[53, 54]. Moreover, the human gut microbiome affects the innate and adaptive im-
mune systems [53, 55]. However, its impact is not restricted to the gut and can
also be manifested in other organs; the incidence of asthma is correlated both with
exposure to bacteria [56] and treatment with broad-spectrum antibiotics in child-
hood [57]. Taken together, those results demonstrate the importance of studying the
human gut microbiome and its effect on health.
2.2.1 Gut microbiome composition
Although studies have demonstrated the importance of the human gut microbiome,
its precise composition remained largely unknown owing to the low number of sam-
ples examined. However, superior sequencing technologies and a reduction in the
cost of sequencing have recently allowed the sequencing of high numbers of samples,
thereby expanding knowledge of human gut microbiome composition. The accu-
rate characterisation of the gut microbiome and its variants is an important step
in defining healthy and unhealthy microbiomes. After the profiling of hundreds of
samples using various technologies, researchers have generally agreed that the hu-
man gut microbiome is mostly composed of four phyla: Actinobacteria, Firmicutes,
Bacteroidetes, and Proteobacteria. Bacteroidetes and Firmicutes represent 90% of
the relative abundance of samples. However, in the gut, these two phyla differ in
their species diversity. Whereas Firmicutes has 12 families with more than 1% of
the gene count, Bacteroidetes has only five. Moreover, members of Firmicutes have
a greater distribution than those of Bacteroidetes. For instance, the most abundant
genera from the Bacteroidetes phylum are Bacteroides and Prevotella, which repre-
sent 80% of all Bacteroidetes in most samples. The gene count is 71% and 7% for
Bacteroides and Prevotella, respectively — because few Prevotella genes have very
high relative abundance in some samples [58]. The phylum Bacteroidetes is com-
posed of Gram-negative, non-endospore-forming, anaerobic bacteria; however, they
are aerotolerant (Figure 2.1) — i.e. they tolerate the presence of oxygen but can-
not use it for growth [59]. The name Firmicutes originates from the Latin ‘firmus’
meaning strong and ‘cutis’ meaning skin. The organisms in this phylum are charac-
terised by a Gram-positive cell wall structure. They are mostly strictly anaerobic,
and some produce endospores. Although Firmicutes is an extremely diverse phylum
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in the gut microbiome, the orders Clostridiales and Lactobacillales contain 67% and
12% of all Firmicutes genes, respectively. The top four Firmicutes families in gene
counts are Lachnospiraceae (23%), Clostridiaceae (19%), Ruminococcaceae (12%),
and Erysipelotrichaceae (10%). This microbiome composition has been described
using various methodologies, such as 16S rRNA, Sanger, 454, and Solexa/Illumina.
Therefore, variations in the microbiome composition are not biased by the distinct
technologies used. In 2009, the relative abundance of Bacteroidetes was demonstrated
to explain a substantial part of the variation in data (Figure 2.2) [60]. However, the
abundance of Bacteroidetes has not been associated with any metadata, and the
cause of the shift from Bacteroidetes to Firmicutes remains unclear. The composi-
tion of the human gut microbiome is similar to that of the mouse microbiome. In
both microbiomes, Bacteroidetes and Firmicutes compose more than 90% of the rel-
ative abundance [21, 48, 61]. This similarity suggests that the composition of the
gut microbiome is defined by a factor that was present in the common ancestry of
humans and mice.
As the abundance of Bacteroidetes can explain most of the variance in the gut mi-
crobiome it became common to plot the distribution sorting the samples by Bac-
teroidetes. This has been publishing in different studies (Figure 2.3), but the con-
clusion about the shifts have been different in each study and in some cases there
were no association found among the shift of the microbiome with diseases or any
metadata. Without a clear explanation this shift has been marginalized and most of
the time present only as supplementary material. Therefore, even when the studies
demonstrate the same microbiome distribution, the conclusion has been not similar.
Until now Bacteroidetes (or only Bacteroides) have been related with obesity (low
Bacteroidetes [60]), high-fiber diet [62] (high levels of Bacteroidetes), protein and
animal fat [63] (high levels of Bacteroides), and no association with BMI [64].
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Figure 2.2: Figure from the article [60] as figure 2b demonstrating that the relative
abundance of Bacteroidetes correlates with PC1 (20%). Because Bacteroidetes and
Firmicutes compose more than 90% of the relative abundance of the human gut
microbiome, the ratio of their relative abundance explains most of the variance in
the data.
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(a) Bacteroidetes/Firmicutes abundance [60]
(b) Firmicutes/Bacteroidetes abundance [65]
Figure 2.3: Data from two studies of human gut microbiota. Although the results of these studies are interpreted in differ-
ent ways, both demonstrate the same shift in human gut microbiota composition, demonstrating the importance of the Bac-
teroidetes/Firmicutes ratio. This abundance shift has also been observed in other studies. The figure 2.3a is the supplementary
information as figure 7 from article [60]. The figure 2.3b is figure 2A from article [65].
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2.2.2 Human gut microbiome shifts related to disease.
The overall composition of the human gut microbiome is described in Section 2.2.1
based on the human gut microbiome catalogue [66]. To put the composition of
the gut in perspective with health status, I describe herein some of the diseases
that have been associated with shifts in gut microbiome composition. Reductions
in the abundance of Firmicutes have been observed in IBD patients [67]. Three
studies have documented that decreases in Firmicutes abundance and increases in
Proteobacteria are associated with Crohn’s disease (CD) [68, 69, 70]. Moreover,
decreases in Firmicutes abundance, specifically that of Faecalibacterium prausnitzii,
has been described in CD [71, 72, 73]. A study of intestinal tissue from IBD patients
has demonstrated that a Prevotella species was 3.6 times more abundant at inflamed
than at non-inflamed sites, with total abundance of Prevotella reaching 25% of the
total community in inflamed samples [68]. A high abundance of members of the
genera Bacteroides and Prevotella in mucosal biopsy specimens from UC patients has
also been reported [74]. In another study using fluorescence in situ hybridisation,
mucosal bacteria were found at concentrations greater than 109/mL in 90–95% of
IBD patients compared with 35% of healthy controls [75]. The mean density of the
mucosal biofilm was two powers higher in IBD patients than in controls, and bacteria
were mostly adherent [75]. Increase in bacterial concentrations was also observed in
IBD patients (Figure 2.4a) [76], T5KO mice (Figure 2.4b) [77], and in Ileitis-induced
by Toxoplasma gondii in mice (Figure 2.4c and 2.4d) [78, 79]. Although all studies
do not agree completely and variation may occur owing to methodology and other
effects, most have consistently reported that reductions in Firmicutes and increases
in Bacteroides, Prevotella, and E. coli are associated with disease. This shift in
composition observed in humans has also been observed in mice (Figure 2.4d) [79].
The similarity in both composition and shifts indicates a common mechanism, which
can modulate the microbiome. In both cases the conclusion is the decrease of Gram-
positive and increase of Gram-negative species [78]. In at least four different studies
was demonstrated that the shift in the microbiome composition (from Firmicutes
to Bacteroidetes) is associated with increase in bacterial concentration (Figure 2.4).
With increase of Gram-negative, especially (Bacteroides, Prevotella, and E. coli).
Bringing the question why increase in bacterial concentration ? And can this increase
have any impact on the diseases ?
2.2.3 Evolution of the gut microbiome
Section 2.2.2 describes the composition of the gut microbiome and its shifts asso-
ciated with disease, both of which are similar between humans and mice, alluding
to their common origin. Moreover, the gut microbiomes of other organisms such as
hoatzins (bird), cows, and macaques are also reportedly dominated by Firmicutes,
Bacteroidetes, Actinobacteria, and Proteobacteria [80, 81]. This composition sug-
gests that the factor, which defines human gut microbiome composition was present
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(a) Increase in bacterial concentrations in IBD patients [76]
(b) Increase in bacterial concen-
tration in T5KO mice [77].
(c) Increase in bacterial concentra-
tion after Ileitis-induced by Toxo-
plasma gondii and indomethacin in
mice [78].
(d) Increase in bacterial concentration from mice with severe ileitis at day
8 after Toxoplasma gondii infection [79].
Figure 2.4: Figure composed of four different studies [76, 77, 78, 79]. In all studies
the shift of the microbiota (from high Firmicutes to high Bacteroidetes and/or E.
coli) is associated with increase in bacterial concentration. Moreover, they also report
decrease in bacteria diversity. Figure 2.4a from study [76] as figure 1. Figure 2.4b in
supplementary information as figure S13b [77]. Figure 2.4c from study [78] as figure
2a. Figure 2.4d from study [79] as figure 3.
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in a common ancestor. This commonality is not surprising given that the first eu-
karyote appeared on Earth approximately 2 billion years ago, and the environment
was dominated by prokaryotes for approximately 1.5 billion years. As eukaryotes sur-
vived and evolved in this environment, they found a means to coexist. The solution
probably occurred through various means, but its basic mechanism may still have
been the same. To defend against other organisms, the first eukaryotes must have
found a way to distinguish their own cells from external ones. Because the human
body is constantly exposed to a large number of microbes, it must recognise its own
cells, avoiding self-attack but also allowing the destruction of harmful organisms.
One important mechanism for the recognition of non-self organisms such as viruses,
bacteria, and fungi was discovered in 1985, when Christiane Nüsslein-Volhard identi-
fied a gene in Drosophila, which can activate immune response. The gene was named
Toll, and since then, Toll-like genes have been observed in many groups of eukaryotes
from plants to animals, suggesting a very early common ancestry [82]. In animals,
Toll-like receptors recognise features that are conserved among microbes, virus, and
fungi located mostly in cell compartments (e.g. flagellin, LPS, double-stranded RNA,
zymosan). The innate immune system is designed to recognise molecules shared by
groups of related microbes. These unique microbial molecules are called microbe-
associated molecular patterns [83]; they are not associated with mammalian cells and
are essential for the survival of microbes. Included in the innate immune response
is the capability to identify molecules shared by a large group of microorganisms
and distinguish them from self, activate a mechanism that eliminates most microbes
within hours, and induce and guide adaptive immune response [84]. Even if species
from the group Homo (e.g. Homo sapiens and Homo erectus) have mechanisms that
are completely different from those of other species to distinguish self and non-self
cells, they would have been defined through human evolution over 2 million years
[85]. Therefore, factors like lifestyle and nationality that are recent in human history
should not affect the microbiota-host relationship or shape gut composition, as has
been suggested before. The gut microbiome and its host form a mutualism relation-
ship where the microbiome provide the host at least two very important functions.
Protective function capable to defend against non-indigenous organisms and capacity
to extract more energy from food. These two functions were extremely important
over millions of years of evolution. Therefore, the evolutionary success of the human
species is associated with the gut microbiota capacity to perform these two functions
in the most optimal way. Thus in section 2.3, I discuss factors that have the most
relevance in defining the composition of the gut microbiome.
2.3 Factors shaping microbiome composition
Since the formation of the IHMC, many articles have discussed the possibility that the
human microbiome is determined by multiple factors — e.g. disease, diet, genotype,
physiology, environment, and immune system — which could shape it into various
forms. Because every individual has been thought to have a common or core micro-
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biome [60], these factors would likely be the main influences in human microbiome
variation (Figure 2.5). The core microbiome theory has lost strength over time as
newer studies have concluded that individuals have unique microbiomes. However,
the idea of multiple factors remains strong, and many researchers have attempted to
explain the variance in gut microbiome composition. Although multiple factors are
likely to contribute to microbiome composition, the relative strength of such factors
remains unknown. Many studies have tried to identify the forces that shape the hu-
man gut microbiome, but most of the results have not been confirmed by additional
studies, which may be due to the use of a low number of samples or lower sequencing
depth. Moreover, some authors have drawn conclusions from their results without
taking into account the influence of all possible factors. In this section, the factors
that have been studied and their effects on the human gut microbiome are discussed.
2.3.1 Impact of genetics on gut microbiome composition
Genotype could contribute to the determination of the human microbiome. To iso-
late this factor, some studies have used samples from twins with obesity and IBD.
Measurements of the distances between samples from obesity using UniFrac have
revealed that samples from monozygotic twins are more similar to each other than
to unrelated or family samples. However, self-sample comparison (i.e. samples from
the same individual) has shown the smallest distance among all comparisons. In
fact, the distance between self and monozygotic twins was greater than that between
monozygotic twins and unrelated individuals. Moreover, the degree of similarity in
the gut bacterial communities of monozygotic twin pairs was not significantly differ-
ent from that between dizygotic twin pairs [60]. If genetics are the most influential
factor in shaping the human gut microbiome, self samples and twin samples should
be very similar in their composition. However, this similarity is absent. Therefore,
other factors may have a greater influence than genetics. Similar results have been
observed in IBD samples. Twin studies for IBD have established that concordance
between both monozygotic and dizygotic twin pairs is 10%–15% for ulcerative colitis
(UC) and 30–35% for CD in monozygotic twins [87]. These results demonstrate that
genetics may have greater influence in some diseases than in others, suggesting, that
a combination of environmental and genetic components are necessary to explain the
observed results.
2.3.2 Impact of diet on gut microbiome composition
The effects of the modern Western diet on the human gut microbiome have been
widely studied, particularly those related to obesity. One review on the influence
of diet on human health has linked diet, gut microbiota, and immune responses to
SCFAs and omega-3 fatty acids [46]. However, the mechanisms through which diet
shapes the human gut microbiome remain unclear. Some authors have claimed that
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Figure 2.5: Figure from an insight article on the human gut microbiome [86] show-
ing factors that may be important in defining its composition. The illustration also
suggests that all individuals have a core microbiome, which provides basic functions
necessary for the human body, and a variable microbiome that would be defined by
the influence of various factors in their individual lives.
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a high-fibre diet is related to high level of Bacteroidetes species, [62] but others have
indicated that high levels of Bacteroides species are associated with diets based on
protein and animal fat [63]. As previously mentioned, members of Bacteroidetes and
Firmicutes are the most abundant phyla in the human gut microbiome, and both
show high variance in samples. Thus, the Bacteroidetes and Firmicutes (B/F) ratio
has been analysed in several studies. The B/F ratio in the mouse microbiome has
been linked to obesity [25]. However, another study found no association between
B/F ratio and body mass index, which is a measure of obesity [64]. In 2010, Alan
Walker [88] analysed the impact of strict diets on the human gut microbiome and
suggested that samples clustered more strongly by individual than by diet, confirming
previous evidence of a stable microbiota. However, Alan Walker also observed an
increase in groups of species after dietary change. For example, a restricted starch
diet increases the abundance of species from Ruminococcus bromii and Eubacterium
rectale [88].
The impact of diet on human health is well known and can be linked to immune
response [46]. However, the claim that diet can shape microbiota composition has
not yet been proved. Moreover, disagreements persist among the conclusions drawn
from diet studies. Studies have interestingly presented data similar to those of pre-
vious microbiome studies (e.g. B/F ratio) but with different interpretations and
conclusions. A recent article by Marcus J. Claesson [89] has suggested that gut mi-
crobiota composition is correlated with diet and health in the elderly. Because the
gut microbiome can be affect by multiple factors, knowing whether the composition
correlates with diet or health is difficult. In addition to the challenge of isolating di-
etary factors in his study, Claesson concluded that such factors “...would be difficult
to correlate with health parameters, but become far more evident in the elderly who
are immunophysiologically compromised”. The association between health in the
elderly and gut inflammation has been demonstrated previously [90]. In addition,
the supplementary material for the Claesson study (figure 9; [89]) demonstrates that
the groups analysed show significant differences in immune system molecules (e.g.
interleukin [IL], IL-6, IL-8, IL-10, tumour necrosis factor-alpha [TNFα]). Together,
these results indicate that diet does not play a central role shaping gut microbiome
composition but is important to health. Moreover, combining the latest results from
Claesson [89] and a review from Kendle Maslowski [46] suggests a larger influence of
the immune system on the gut microbiota than previous thought.
2.3.3 Impact of the immune system on gut microbiome com-
position
The human intestines have the largest surface area of any organ in the human body
at ∼ 200 m2 (the skin has only ∼ 2 m2). The intestines also harbour the most diverse
and dense microbial communities in the body, with more than 1012/cm3 of intestinal
content. A very thin epithelial layer (10 µm) and mucus separates this enormous
bacteria community from body tissues. The layer is divided into inner and outer
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layers, and total mucus thickness varies from 15 to 700 µm [91]. The large intestine
has the thickest layer, which may be related to its higher concentration of bacteria
[92]. The idea that the immune system influences gut microbiome composition is
related to the fact that the intestine is the largest interface between the immune
system and the environment. Just the presence of commensal bacteria in the gut
is enough to induce low-grade inflammation which is absent in newborn humans
and germ-free mice [93, 94, 95]. Some publications linking the immune system with
inflammatory diseases like IBD have confirmed shifts in the microbiome composition
in humans and mice. For instance, an increase in Prevotella abundance has been
identified in inflamed intestinal tissue from IBD patients [68], and high abundance
of Bacteroides and Prevotella have been observed in UC patients [74]. Similar shift
have been observed in other studies of patients with IBD [68] and obesity [96]. The
same shift was observed in mice when immune system genes (e.g. Nlrp6−/−, Nlrp3−/−,
Rag−/−, and T5KO) were knocked out [97, 98, 99, 77], and in non-obese diabetic mice
the absence of MyD88 increases the abundance of the Bacteroidetes phylum [100].
Recently, a similar shift was discovered in a murine model of ileal CD, characterised by
a decrease in Firmicutes (Gram-positive) and an increase in Proteobacteria (Gram-
negative) with reduction in diversity [78].
Reduction in diversity has been extensively reported in many diseases under study.
Moreover, increases in bacteria concentration have also been observed in IBD pa-
tients [76, 75]. Unfortunately, few studies have measured important variables such
as microbiota composition, immune response, species diversity, and bacterial concen-
tration. It may seem illogical that diversity decreases when bacteria concentration
increases, but this observation has been confirmed not only in the gut microbial com-
position but also in other microbial ecological systems [101, 102]. A 2006 study by
Markus M. Heimesaat [79] includes all important variables, explaining for probably
the first time the dynamics of the human gut microbiome ecosystem. Heimesaat
reported that “analysis of the intestinal microflora revealed that ileitis (inflammation
of the ileum) was accompanied by increasing bacterial load, decreasing species diver-
sity, and bacterial translocation. Gram-negative bacteria identified as Escherichia
coli and Bacteroides/Prevotella spp. accumulated in inflamed ileum at high concen-
trations”. In the same report, he demonstrates that antibiotic treatment prevented
ileitis. The decrease in Gram-positive bacteria and increase in Gram-negative bac-
teria tolerant of oxygen suggest an important role for the innate immune system in
shaping human gut microbiome composition. Shifts in microbiota composition are
not linked only to gut-related diseases. Other inflammation-related diseases have
been accompanied by similar shifts in microbiota. A review by Mairi Noverr and
Gary B. Huffnagle [103] explores whether gut microbiota regulate immune response
outside of the gut. The results indicated that alterations in intestinal microbiota are
linked to obesity, asthma, diabetes, IBD, and other inflammatory conditions. For
instance, infants with atopy display fewer bifidobacteria in stool [104]. Rheumatoid
arthritis is associated with a reduction in anaerobic bacteria [105] and a reduction
in bifidobacteria, Eubacterium rectale, and Bacteroidetes [106]. This suggest the link
microbiome-inflammation may have consequences in other parts of our body. In-
dicating a bigger importance of the human gut microbiome then previous though.
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A recent review by Lora Hooper [91] aggregates conclusions about the impact of
the immune system on gut microbiome composition and concludes that “it is now
clear that the immune system plays a central role in shaping the composition of the
microbiota as well as its proximity to host tissues”.
2.4 Applying ecology to explain the human gut mi-
crobiome.
One of the main goals of the IHMC is to understand the relationship between the mi-
crobiome and disease. Thus, IBD (e.g. CD and UC) have been extensively studied.
The search for biomarker species, which can explain the links among gut microbiome
and disease have been the focus of most of these studies. Using classic two-group
analyses, these studies have separated data into healthy and unhealthy groups, look-
ing for one bacterial species responsible for disease. However, multiple studies to
date have been unable to find pathogenic species to explain diseases such as IBD
and obesity. The lack of biomarkers has been surprising, because the influence of
the microbiome in disease has been established. For example, in human and murine
models of disease, the use of antibiotics reduces or prevents inflammation, suggesting
an important role for the gut microbiome in disease [107, 75]. Moreover, a protec-
tive role for the microbiome has been indicated when germ-free mice develop disease
(induced by dextran sulphate sodium) more severe than that in mice with normal
flora [108]. Because studies have been unable to find disease-associated biomarkers,
an alternative explanation for the microbiota–disease relationship has been gaining
strength. Several opinion, perspective, and review articles have suggested that dise-
quilibrium in the microbial ecosystem — known as dysbiosis — is a possible mecha-
nism [109, 110, 28, 111, 112, 113]. At the same time, many researchers have identified
differences in diversity (defined by the Shannon’s diversity index, including richness
[or alpha-diversity] and evenness) between healthy individuals and those with dis-
ease. Unhealthy individuals with low-diversity microbiomes have been consistently
reported (Figure 2.6) [58, 60, 68, 114].
These data imply that the role of the human gut microbiome in disease may be
different than expected. The use of ecology theory has recently been proposed as a
way to understand the human gut microbiome [28]. One of the interesting points of
this suggestion is the idea of alternative stages of the microbiome in a community
stage landscape. The theory of alternative stages suggests that a community can shift
directly (e.g. antibiotics) or indirectly (e.g. environmental factors and immunity),
changing from one stable stage to another. The third article presented in this thesis
describes the application of ecological theory to explain the shifts observed in the
human gut microbiome. Thus, in this section I explain ecology features used in the
last article.
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(a) Measures of bacterial diversity in IBD pa-
tients. [68]
(b) Microbial biodiversity is reduced in children
with severe UC [114].
(c) Distribution of nonredundant bacterial genes
in IBD patients and healthy controls [66].
(d) Diversity of lean and obese individuals [60].
Figure 2.6: Data from four studies showing that unhealthy individuals have lower
microbiome diversity than that of healthy individuals. Figure 2.6a is figure 3b from
article [68]. Figure 2.6b is figure 1 from article [114]. Figure 2.6c is supplementary
figure 8 from article [66]. Figure 2.6d is figure 1b from article [60].
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2.4.1 Diversity
This section discusses the various types of diversity measurements often used in
ecological studies. Many of these methods are used in the third study presented below
and are important to explanations of shifts in human gut microbiome composition.
This discussion will help readers who are unfamiliar with ecological terms and theory
to understand the meaning of the study results and conclusions. Some differences
exist between the traditional use of ecological indices and their use in metagenomics
and microbial ecology. For instance, spatial analysis (i.e. topological, geometric, or
geographic properties) is not used to investigate the human gut microbiome because
most of the studies use stool samples. Another important point is the lack of absolute
measurements. Most of the studies to date have not included values of absolute
abundance; consequently, it is unknown whether 1 gram or 30 grams of stool were
required to extract the necessary amount of DNA for sequencing. This information
can be invaluable, as it indicates the concentration of bacteria in the ecosystem, which
may be relevant to explanations of the microbiota–disease link. In the near future,
this information may be more commonly included in the analysis. Currently, however,
most studies of the human gut microbiome using metagenomic sequencing refer to
their abundance as relative and not absolute. Thus, the abundance of a species will
always be a proportion of the total, which allows the comparison of relative changes
between samples. Moreover, the abundance of the species will be influenced by the
richness of the sample. For instance, if one sample has 100 species and the distribution
of the species is even, then each species should have 1% relative abundance. If another
sample has 200 species with even distribution, then the expected abundance of each
species is 0.5%. Consequently, richness affects the relative abundance of the species
in a sample. Finally, a sample may contain only four species with the same absolute
abundance as a 100 species sample and the same evenness, but the relative abundance
of those species will be 25%. Therefore, results from relative abundance data must
be interpreted carefully.
Diversity, according to ecologists, is the measurement of two features of an ecosystem:
the total number of species present in an ecosystem (i.e. richness) and the evenness
of their distribution (i.e. evenness). It is important to emphasise that richness is the
total number of species found in one habitat and is unrelated to the total number
of individuals present. Traditionally, ecology studies cannot measure the whole com-
munity at once and the analysis of alpha diversity is determined through multiple
samples of the ecosystem. Then the mean of the samples is used to determine alpha
diversity, including the proportional abundance of species. The use of metagenomics
in microbial ecology allows the sampling of the whole environment at once and, in
most studies, the sample is sequenced only once owing to high sequencing costs. Be-
cause multiple sampling does not take place and the entire habitat can be profiled at
once, richness is used instead of alpha diversity. The index of diversity is the combi-
nation of richness and evenness. One of the most popular diversity indices currently
used is the Shannon diversity index; however, many other methods are appropriate.
One of the main differences among indices is the method for weighing rare species.
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The third article presented in this thesis and most of the studies published to date
use the Shannon’s diversity index (Formula 1):
H ′ = −
R∑
i=1
[pi × log(pi)]
Formula 1: Shannon’s diversity index. R is richness and pi is the proportion of the
species abundance in the habitat. Any log base can be used, but traditionally is has
been used log base 2.
Evenness is an important measurement, because two ecosystems can have the same
richness and total number of individuals but very different evenness. A simple ex-
planation can be observed (Figure 2.7), in which each system has the same amount
of richness (four species) and a total of 12 individuals. Intuitively, system ‘A’ is less
diverse then system ‘B’ because system ‘A’ is composed mostly by one species. This
formula can transform this intuition into a value that can be used for the evenness
formula from the Shannon diversity index (Formula 2):
E =
H ′
log(R)
Formula 2: Evenness index from Shannon’s diversity index. E is the evenness index,
H is the Shannon’s diversity index and R is richness.
Beta diversity is used to calculate the difference in richness between two habitats
and is often used to create a distance matrix among habitats to produce clusters
of samples. However, it does not explain how different the communities are. To
calculate beta diversity, we first need to explain gamma diversity. Gamma diversity
is the total number of unique species observed in two habitats. In figure 2.8, the
gamma diversity is 4 — the same value as richness — and both ecosystems have the
same type of species. Beta diversity is calculated by dividing gamma diversity by
alpha diversity (in this case, richness). However, beta diversity does not tell much
about how different these ecosystems are, and one of the most important problems
in studies of the human gut microbiome is determining whether one ecosystem is a
subset of another or completely new. To solve this problem, I created a new diversity
index called delta diversity, following the diversity indices created by Robert Harding
Whittaker [115]. Delta diversity calculates the number of unique species that are
shared by two ecosystems. To quantify how similar a lower-diversity ecosystem is to
a higher-diversity ecosystem, I divided delta diversity by richness (or alpha diversity)
from the ecosystem with the low Shannon diversity index (Formula 3):
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Figure 2.7: Both ecosystems have a species richness value of 4 and a total of 12
individuals. The figure demonstrates how richness and total number of individuals
in some cases incapable of explaining diversity. Each colour and shape represents
a different bacterial species. Comparing the two biota reveals that ecosystem ‘A’ is
dominated by one species, whereas ecosystem ‘B’ has even distribution of species.
Therefore, ‘B’ has higher diversity than ‘A’.
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δ = RH ∩RL
Formula 3: Delta diversity as the intersection of the richness from the high with rich-
ness from the low diversity ecosystem. δ as delta diversity representing the number
of unique species which are shared among two ecosystems, RH the richness from the
ecosystem with the highest diversity and RL the richness of low diversity ecosystem.
∆ =
δ
RL
Formula 4: Proportion of delta diversity: ∆ is the similarity measurement among
two ecosystems; δ is the number of unique species shared among two ecosystems,
RL the richness of low diversity sample. The same formula can be calculated using
alpha-diversity following the same logic.
Delta diversity is the proportion of species in the low-diversity species that is present
in the high-diversity species (Formula 4). The assumption is that if two ecosystems
are likely to be related, then most of the species in the low-diversity ecosystem should
be present in the high-diversity system. The higher the proportion, the higher the
likelihood that one ecosystem is related to the other. For instance, an ecosystem
displays decreased diversity if it is under any perturbation, thereby losing species
richness. Based on beta diversity, those ecosystems might be considered different,
but delta diversity reveals that the low-diversity ecosystem is a subgroup of the high-
diversity ecosystem. In this case, the main difference between the two ecosystems is
the variance in abundance in addition to the loss of richness. When one system is a
subgroup of another system, the overall system can be described as nested, a concept
discussed in Section 2.4.2.
2.4.2 Network
In nature, most organisms do not exist alone and must interact with other species.
Only rarely do samples from an environment contain cells from just one species.
This generalization is true even for high eukaryotes, including humans: 90% of cells
in the human body are actually bacteria from thousands of different species. The
mechanisms of interactions among bacteria and between bacteria and their hosts
are unknown. Therefore, some important questions should be addressed: Do species
preferentially interact with a certain taxonomic group? Which species are dependent,
and which are self-sufficient? Which microbes interact with one other? What are the
dynamics of the ecosystem under pressure? Answering these questions is biologically
32 Microbiology
Figure 2.8: Diversity among three ecosystems. This example depicts how richness
and beta, gamma, and delta diversity are calculated. Each diversity measurement
explains some of the differences between the ecosystems. Many studies have used
beta diversity to calculate the difference between ecosystems. However, beta diversity
cannot explain whether one ecosystem is subset of another ecosystem or is a new
ecosystem, composed completely of new species. In this example, ‘Blue’ is a subgroup
of ‘Red’, and ‘Green’ is an ecosystem composed mostly by new species.
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relevant, and understanding ecosystem dynamics may have medical implications. In
this section, I explain three important concepts of microbial interaction.
2.4.2.1 Ecological relationship
In ecology, the interaction of any species with another can be classified as a type
of relationship. Relationship categories were introduced by William Lidicker [116]
and are based on the effect that occurs between the species. For instance, when
a relationship is beneficial for both species, it is called mutualism, and when it is
disadvantageous for both, it is called competition. In some cases, a relationship can
be positive for one species and negative for another — e.g. parasitism. The ecological
relationship model is important in this thesis to explain the interaction among the
species in a network. However, defining exactly which type of relationship occurs
between two species requires experimental analysis beyond the scope of this study.
A general categorization of the interaction was made instead, and relationships were
simplified in two types — positive and negative. Any positive interaction could be
positive-positive or positive-neutral, and the same possibilities applied to negative
relationships.
2.4.3 Microbial ecological network
An ecological network is a representation of the interaction among species in which
species are represented as nodes and associations among species are designated by
a link connecting them. The properties of these two features are, in general, used
to explain the nodes and interactions further. For example, node size is commonly
represented as the abundance of the organism, and its colour represents the taxo-
nomic group. The associations are represented by arrows that indicate the direction
of the relationship. This information was unavailable for the thesis studies. Thus,
in microbial networks, colour is commonly used to represent positive and negative
interactions (blue and red, respectively). The transparency of the colour can also be
used to explain how strong associations are, with weak associations close to white
and the colour darkening with the growing strength of the association. These colour
assignments provide a visual representation of the relationship and emphasise the
strongest links in a complex network. To shed light on some of the questions above,
we built the first species network of the human gut microbiome using the species
abundance concepts presented in the first article below [66]. The approach is based
on the presumption that if samples of two species show co-abundance, they may have
an association. The assumption becomes stronger as more samples are analysed.
Figure 2.9 displays the steps necessary to build a microbial network. The micro-
bial abundance network starts with the genes abundance for each sample. Which
in sequencing is measured by count of reads and in microarray by signal. Genes
are combined to form species using taxonomy classification. The abundance of the
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species is determinated by the median abundance of the genes. Creating the species
abundance matrix. Then a method to find the pairwise relationship is used. Several
methods are appropriate, and they are thoroughly discussed in a recent review [117].
The methods create a matrix with pairwise scores, which are filtered by the user
to determinate which species are associated. Positive associations means that both
species have the same abundance profile and will therefore increase and decrease in
abundance together. A negative association occurs when two species have opposite
abundance profiles; therefore, when one increases in abundance the other decreases.
Although this approach may be simple, it can aid the search for answers to the
questions posed at the beginning of this section.
The microbial abundance network permits the identification of bacterial interactions
from among hundreds of species. We can also observe whether a species from a
taxonomic group will preferentially interact with the same group or another, often
revealing some unexpected associations among different phyla. Another interesting
insight is the level of independence that a bacterium or a group of bacteria display.
For instance, a lack of association with other species or group of species may indi-
cate that a species can be present in samples without the presence of other species,
suggesting that it is self-sustaining. The network also reveals whether one group of
species is more dependent than another and identifies the organism with the high-
est level of dependency. This species may be important in the ecosystem, and if it
disappears, other species may be affected, in turn becoming lower in abundance or
even disappearing completely.
2.4.4 Properties of ecological networks
Ecological networks are important tools with which to explain ecosystems. The rep-
resentation of species interactions is just one of many relevant properties. Ecologists
study networks using empirical data and model their dynamics with the goal of
identifying common patterns among various ecosystems. Those patterns are basic
mechanisms, which can explain the emergence of an ecosystem and its dynamics.
Therefore, these properties can be used to describe an ecological network more thor-
oughly. Herein I discuss some of the properties that are used in the third article
presented in this thesis. These properties are keys for understanding the study re-
sults and their relationship with other ecosystem studies.
Ecological networks were first developed by ecologists to explain food web interac-
tions. In food webs, specialist and generalist species are defined by their diet ranges.
Species, which fed on only a few species, are considered specialists and those with
a broader dietary range are generalists. This concept was extended and can also be
applied to the capacity of an organism to survive in a specific environment. For ex-
ample, some plants can survive only within a narrow range of temperature, humidity,
rainfall, and sun exposure. Changes in the ecosystem are more likely to influence
specialist than generalists. Species degree is a property of the ecological network,
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Figure 2.9: Figure explaining the steps necessary to build a microbial ecological
network. Figure 2.9A gene abundance matrix where colours represent the taxonomic
classification. Figure 2.9B species matrix with the abundance of each species per
sample. Figure 2.9C pairwise correlation matrix among all species. Blue colour
represent positive association and red colour negative. The intensity of the colour
represent how strong are the association. Figure 2.9D Network output from created
from the association matrix.
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which describes the number of associations a species has with other species in a net-
work. In food web networks, generalists have higher species degrees (i.e. the species
feeds on a broader range other species) and specialists have lower species degrees
representing their limited diet. However, networks based on the capacity to adapt
to changes in the environment reflect the opposite characteristics. Generalists have
species degrees lower than those of specialists. An environment that remains stable
generates specialization — e.g. a fish and its parasite will co-evolve. The co-evolution
confers greater advantage to species living in that niche and introduces barriers for
alien species (species that did not co-evolve in the environment) to colonise the niche.
The stable and strict environment increases biodiversity through specialist species
evolution. The relationship of specialist species in stable environments is, in general,
mutualistic among the species and possibly with the host. Therefore, networks re-
flecting adaptation in a stable environment have greater species degrees in specialist
species and lower degrees in generalists. Where the specialist species provides the
most optimised function within an environment, the generalist provides less optimal
functions when the ecosystem is under perturbation.
Two concepts of nestedness, which are important in this thesis, occur in ecological
networks. The first concept originates in food web networks in which specialists nest
with a subset of generalist species. The second concept is an extension of nestedness
and is applied to comparisons of networks (from different habitats or in biodiversity
conservation studies). Bruce Patterson [118] defined the principle of nestedness in
1987. A biota is considered nested if the species present (elements contained) in
small biotas are also present in richer ones. In a non-nested biota, species in low-
diversity ecosystems differ from those in high-diversity ecosystems. An ecosystem
under pressure loses species (richness), transforming into a subset of the original
biota; it cannot be considered a new ecosystem.
The stability of networks has been the subject of study for many years. In 1984,
Stuard Pimm concluded in a review that complexity leads to instability [119]. The
definition of complexity in a network is based on the number of species degrees divided
by the number of species in the network. Thus, a complex network has many links
among species. Pimm’s theory is that if one key member of a network disappears, all
dependent species also die. Therefore, complexity leads to instability. However, new
features such as compartmentalisation increase the stability of the network. Com-
partmentalisation occurs when a network consists of subnetworks or a large network
composed of smaller networks connected by very few species. Moreover, an increase
in interaction among species decreases interaction strength. For instance, if species
‘A’ has only one interaction with ‘B’, its interaction will be very strong and depen-
dent. However, if A interacts with five species, the interactions will be weaker, and
disturbances in the ecosystem will not affect the overall network. Therefore, increased
interactions lead to a stable ecosystem. Network stability is an important feature
because it can determine the capacity to withstand and recover from perturbations.
Resilience is the capacity of an ecosystem to be disturbed and recover quickly. Most
ecosystems have levels of stability and resilience because they are all exposed to
stochastic events (e.g. fire, flooding, hurricane, earthquakes, insect plagues, and dis-
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ease). Long-term, high-magnitude disturbances can pass the threshold of resilience
to a point at which the ecosystem can never recover, allowing a different biota to
take over. Because most ecosystems are stable, their level of resilience is adequate
to withstand some level of perturbation and restore original composition. Therefore,
ecosystems are likely to display various stages in which species with higher capacities
for adaptation to change (generalists) survive and specialists die.
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Chapter 3
Results
3.1 Article 1: “A human gut microbial gene cata-
logue established by metagenomic sequencing”.
In 2010, few studies on the sequencing of metagenomic samples using NGS had been
published. The studies that were available answered the question, ‘who is there?’
and showed that the number of species in the human gut microbiome is higher than
that in other environments. Unfortunately, the low number of analysed samples
compromised more complex analyses, which might have revealed the role of the
microbiota in disease. Interestingly, every subject had a unique microbiome at a
low taxonomy level, demonstrating the complexity of the human gut microbiome.
Creating a reference genome is an important step in understanding the differences
and functional capacities of the gut microbiome. Because most of the published
articles used 16S rRNA, a human gut microbiome ‘genome’ (gene catalogue) was
still far from available.
Many species of bacteria in the human gut cannot be cultivated, so the creation of
such a catalogue of the microbiome required metagenomic sequencing. Hence, the
MetaHIT consortium undertook the sequencing of a large number of metagenomic
samples from healthy individuals and those with obesity and IBD. The goal was to
identify all of the genes that can exist and determine how many genes are present in
any human gut microbiome, which is considered a second genome. The publication
of this article was a major breakthrough. It was the largest dataset sequenced in
a metagenomic project and demonstrated how NGS is presenting opportunities to
study complex systems and diseases. At that time, a discussion was ongoing in
the scientific community about whether short reads could be assembled into long
contigs. This article demonstrates that short reads can generate contigs that are
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long enough for the extraction of biological information — e.g. genes. A substantial
portion of the article was dedicated to demonstrating that short reads could generate
the same information as 454 and Sanger sequencing but with greater depth. With
its high number of samples and great sequencing depth, this project was the first
to produce sequence data adequate to saturate the number of unique genes, which
was demonstrated using rarefaction curves. As a result, this project assembled large
contigs, identified almost all of the possible genes in the human gut microbiome, and
generated a human gut microbiome catalogue (a reference genome) with 3.3 million
genes. Although the main aim of the study was to create a microbiome catalogue
and prove that metagenomic sequencing could be carried out using short reads, some
biological analyses for genomic and metagenomic data were also performed. As
part of my work in MetaHIT, a network analysis was carried out to evaluate the
data from a systems biology perspective. Using a technique similar to that of co-
expressed genes, often used in transcription analysis to cluster genes that are co-
expressed, we clustered species with co-abundance throughout the samples. We
also applied the same principal to genes, clustering genes with co-abundance to find
unknown species (metagenomic species; publication not included in this thesis). The
main goal was to try to understand how bacteria interact with one another in such
a complex environment. Because this type of analysis had never been performed
on such a large and complex dataset, new tools were developed to undertake the
analysis. My work included defining species abundance using gene abundance and
generating taxonomy for each gene. Using the gene count for each sample and the
taxonomy for each gene, I calculated species abundance for each organism. The
species abundance correlation was then observed to define how species are connected
(Figure 3.1). The network provides a first look at how species may be interacting
in the human gut and revealed some unexpected results. The network shows that
Bacteroides species have low numbers of species degrees (number of connections
with other species) and Firmicutes species have high number of species degrees.
Moreover, Bacteroides species have higher median abundance then that of most of
the Firmicutes species. The result of this study had a significant impact on the
scientific community. Microbiologists were particularly interested in the network
because for the first time, they gained access to information about which bacteria
are connected to one another. For example, one important result was the anti-
correlated interaction of F. prausnitzii with two Clostridium species, which might
have implications for human health because F. prausnitzii is an anti-inflammatory
commensal bacterium that may play an important role in IBD.
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Figure 3.1: First human gut microbiome network revealing how species are connected and how the two major groups (Firmicutes
and Bacteroidetes) are distribuited. Figure from [66] as supplementary information figure 9.
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To understand the impact of gut microbes on human health and well-being it is crucial to assess their genetic potential. Here
we describe the Illumina-based metagenomic sequencing, assembly and characterization of 3.3 million non-redundant
microbial genes, derived from 576.7 gigabases of sequence, from faecal samples of 124 European individuals. The gene set,
,150 times larger than the human gene complement, contains an overwhelming majority of the prevalent (more frequent)
microbial genes of the cohort and probably includes a large proportion of the prevalent human intestinalmicrobial genes. The
genes are largely shared among individuals of the cohort. Over 99% of the genes are bacterial, indicating that the entire
cohort harbours between 1,000 and 1,150 prevalent bacterial species and each individual at least 160 such species, which are
also largely shared. We define and describe the minimal gut metagenome and the minimal gut bacterial genome in terms of
functions present in all individuals and most bacteria, respectively.
It has been estimated that the microbes in our bodies collectively
make up to 100 trillion cells, tenfold the number of human cells,
and suggested that they encode 100-fold more unique genes than
our own genome1. The majority of microbes reside in the gut, have
a profound influence on human physiology and nutrition, and are
crucial for human life2,3. Furthermore, the gutmicrobes contribute to
energy harvest from food, and changes of gut microbiome may be
associated with bowel diseases or obesity4–8.
To understand and exploit the impact of the gut microbes on
human health and well-being it is necessary to decipher the content,
diversity and functioning of the microbial gut community. 16S ribo-
somal RNA gene (rRNA) sequence-basedmethods9 revealed that two
bacterial divisions, the Bacteroidetes and the Firmicutes, constitute
over 90% of the known phylogenetic categories and dominate the
distal gut microbiota10. Studies also showed substantial diversity of
the gutmicrobiome between healthy individuals4,8,10,11. Although this
difference is especially marked among infants12, later in life the gut
microbiome converges to more similar phyla.
Metagenomic sequencing represents a powerful alternative to
rRNA sequencing for analysing complexmicrobial communities13–15.
Applied to the human gut, such studies have already generated some
3 gigabases (Gb) of microbial sequence from faecal samples of 33
individuals from the United States or Japan8,16,17. To get a broader
overview of the human gut microbial genes we used the Illumina
Genome Analyser (GA) technology to carry out deep sequencing of
total DNA from faecal samples of 124 European adults.We generated
576.7 Gb of sequence, almost 200 times more than in all previous
studies, assembled it into contigs and predicted 3.3 million unique
open reading frames (ORFs). This gene catalogue contains virtually
all of the prevalent gut microbial genes in our cohort, provides a
broad view of the functions important for bacterial life in the gut
and indicates that many bacterial species are shared by different
individuals. Our results also show that short-read metagenomic
sequencing can be used for global characterization of the genetic
potential of ecologically complex environments.
Metagenomic sequencing of gut microbiomes
As part of the MetaHIT (Metagenomics of the Human Intestinal
Tract) project, we collected faecal specimens from 124 healthy, over-
weight and obese individual human adults, as well as inflammatory
bowel disease (IBD) patients, fromDenmark and Spain (Supplemen-
tary Table 1). Total DNA was extracted from the faecal specimens18
and an average of 4.5 Gb (ranging between 2 and 7.3Gb) of sequence
was generated for each sample, allowing us to capture most of the
*These authors contributed equally to this work.
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novelty (see Methods and Supplementary Table 2). In total, we
obtained 576.7 Gb of sequence (Supplementary Table 3).
Wanting to generate an extensive catalogue ofmicrobial genes from
the human gut, we first assembled the short Illumina reads into longer
contigs, which could then be analysed and annotated by standard
methods.Using SOAPdenovo19, a de Bruijn graph-based tool specially
designed for assembling very short reads, we performed de novo
assembly for all of the Illumina GA sequence data. Because a high
diversity between individuals is expected8,16,17, we first assembled each
sample independently (Supplementary Fig. 3). As much as 42.7% of
the Illumina GA reads was assembled into a total of 6.58 million
contigs of a length .500 bp, giving a total contig length of 10.3Gb,
with an N50 length of 2.2 kb (Supplementary Fig. 4) and the range of
12.3 to 237.6Mb (Supplementary Table 4). Almost 35%of reads from
any one sample could be mapped to contigs from other samples,
indicating the existence of a common sequence core.
To assess the quality of the IlluminaGA-based assemblywemapped
the contigs of samplesMH0006 andMH0012 to the Sanger reads from
the same samples (Supplementary Table 2). A total of 98.7% of the
contigs that map to at least one Sanger read were collinear over 99.6%
of the mapped regions. This is comparable to the contigs that were
generated by 454 sequencing for one of the two samples (MH0006) as
a control, of which 97.9% were collinear over 99.5% of the mapped
regions.We estimate assembly errors to be 14.2 and 20.7 permegabase
(Mb) of Illumina- and 454-based contigs, respectively (see Methods
and Supplementary Fig. 5), indicating that the short- and long-read-
based assemblies have comparable accuracies.
To complete the contig set we pooled the unassembled reads from
all 124 samples, and repeated the de novo assembly process. About 0.4
million additional contigs were thus generated, having a length of
370Mb and an N50 length of 939 bp. The total length of our final
contig set was thus 10.7 Gb. Some 80% of the 576.7Gb of Illumina
GA sequence could be aligned to the contigs at a threshold of 90%
identity, allowing for accommodation of sequencing errors and
strain variability in the gut (Fig. 1), almost twice the 42.7% of
sequence that was assembled into contigs by SOAPdenovo, because
assembly uses more stringent criteria. This indicates that a vast
majority of the Illumina sequence is represented by our contigs.
To compare the representation of the human gut microbiome in
our contigs with that from previous work, we aligned them to the
reads from the two largest published gut metagenome studies
(1.83Gb of Roche/454 sequencing reads from 18 US adults8, and
0.79Gb of Sanger reads from 13 Japanese adults and infants17), using
the 90% identity threshold. A total of 70.1% and 85.9% of the reads
from the Japanese and US samples, respectively, could be aligned to
our contigs (Fig. 1), showing that the contigs include a high fraction
of sequences from previous studies. In contrast, 85.7% and 69.5% of
our contigs were not covered by the reads from the Japanese and US
samples, respectively, highlighting the novelty we captured.
Only 31.0–48.8% of the reads from the two previous studies and
the present study could be aligned to 194 public human gut bacterial
genomes (Supplementary Table 5), and 7.6–21.2% to the bacterial
genomes deposited in GenBank (Fig. 1). This indicates that the
reference gene set obtained by sequencing genomes of isolated bac-
terial strains is still of a limited scale.
A gene catalogue of the human gut microbiome
To establish a non-redundant human gut microbiome gene set we
first used the MetaGene20 program to predict ORFs in our contigs
and found 14,048,045 ORFs longer than 100 bp (Supplementary
Table 6). They occupied 86.7% of the contigs, comparable to the
value found for fully sequenced genomes (,86%). Two-thirds of
theORFs appeared incomplete, possibly due to the size of our contigs
(N50 of 2.2 kb). We next removed the redundant ORFs, by pair-wise
comparison, using a very stringent criterion of 95% identity over
90% of the shorter ORF length, which can fuse orthologues but
avoids inflation of the data set due to possible sequencing errors
(see Methods). Yet, the final non-redundant gene set contained as
many as 3,299,822 ORFs with an average length of 704 bp (Sup-
plementary Table 7).
We term the genes of the non-redundant set ‘prevalent genes’, as
they are encoded on contigs assembled from themost abundant reads
(see Methods). The minimal relative abundance of the prevalent
genes was ,63 1027, as estimated from the minimum sequence
coverage of the unique genes (close to 3), and the total Illumina
sequence length generated for each individual (on average, 4.5 Gb),
assuming the average gene length of 0.85 kb (that is, 33 0.853 103/
4.53 109).
We mapped the 3.3 million gut ORFs to the 319,812 genes (target
genes) of the 89 frequent reference microbial genomes in the human
gut. At a 90% identity threshold, 80% of the target genes had at least
80% of their length covered by a single gut ORF (Fig. 2b). This
indicates that the gene set includes most of the known human gut
bacterial genes.
We examined the number of prevalent genes identified across all
individuals as a function of the extent of sequencing, demanding at
least two supporting reads for a gene call (Fig. 2a). The incidence-
based coverage richness estimator (ICE), determined at 100 individuals
(the highest number the EstimateS21 program could accommodate),
indicates that our catalogue captures 85.3% of the prevalent genes.
Although this is probably an underestimate, it nevertheless indicates
that the catalogue contains an overwhelmingmajority of the prevalent
genes of the cohort.
Each individual carried 536,1126 12,167 (mean6 s.e.m.) prevalent
genes (Supplementary Fig. 6b), indicating that most of the 3.3 million
gene pool must be shared. However, most of the prevalent genes were
found in only a few individuals: 2,375,655 were present in less than
20%, whereas 294,110 were found in at least 50% of individuals (we
term these ‘common’ genes). These values depend on the sampling
depth; sequencing of MH0006 and MH0012 revealed more of the
catalogue genes, present at a low abundance (Supplementary Fig. 7).
Nevertheless, even at our routine sampling depth, each individual
harboured 204,0566 3,603 (mean6 s.e.m.) common genes, indi-
cating that about 38% of an individual’s total gene pool is shared.
Interestingly, the IBDpatients harboured, on average, 25% fewer genes
than the individuals not suffering from IBD (Supplementary Fig. 8),
consistent with the observation that the former have lower bacterial
diversity than the latter22.
Common bacterial core
Deep metagenomic sequencing provides the opportunity to explore
the existence of a common set of microbial species (common core) in
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Figure 1 | Coverage of human gut microbiome. The three human microbial
sequencing read sets—Illumina GA reads generated from 124 individuals in
this study (black; n5 124), Roche/454 reads from 18 human twins and their
mothers (grey; n5 18) and Sanger reads from 13 Japanese individuals
(white; n5 13)—were aligned to each of the reference sequence sets. Mean
values6 s.e.m. are plotted.
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the cohort. For this purpose, we used a non-redundant set of 650
sequenced bacterial and archaeal genomes (seeMethods).We aligned
the Illumina GA reads of each human gut microbial sample onto the
genome set, using a 90% identity threshold, and determined the
proportion of the genomes covered by the reads that aligned onto
only a single position in the set. At a 1% coverage, which for a typical
gut bacterial genome corresponds to an average length of about
40 kb, some 25-fold more than that of the 16S gene generally used
for species identification, we detected 18 species in all individuals, 57
in$90% and 75 in$50%of individuals (Supplementary Table 8). At
10% coverage, requiring,10-fold higher abundance in a sample, we
still found 13 of the above species in$90% of individuals and 35
in$50%.
When the cumulated sequence length increased from 3.96Gb to
8.74Gb and from 4.41Gb to 11.6Gb, for samples MH0006 and
MH0012, respectively, the number of strains common to the two
at the 1% coverage threshold increased by 25%, from 135 to 169.
This indicates the existence of a significantly larger common core
than the one we could observe at the sequence depth routinely used
for each individual.
The variability of abundance of microbial species in individuals
can greatly affect identification of the common core. To visualize
this variability, we compared the number of sequencing reads aligned
to different genomes across the individuals of our cohort. Even for
the most common 57 species present in$90% of individuals with
genome coverage.1% (Supplementary Table 8), the inter-individual
variability was between 12- and 2,187-fold (Fig. 3). As expected10,23,
Bacteroidetes and Firmicutes had the highest abundance.
A complex pattern of species relatedness, characterized by clusters
at the genus and family levels, emerges from the analysis of the net-
work based on the pair-wise Pearson correlation coefficients of 155
species present in at least one individual at$1% coverage
(Supplementary Fig. 9). Prominent clusters include some of themost
abundant gut species, such as members of the Bacteroidetes and
Dorea/Eubacterium/Ruminococcus groups and also bifidobacteria,
Proteobacteria and streptococci/lactobacilli groups. These observa-
tions indicate that similar constellations of bacteriamay be present in
different individuals of our cohort, for reasons that remain to be
established.
The above result indicates that the Illumina-based bacterial pro-
filing should reveal differences between the healthy individuals and
patients. To test this hypothesis we compared the IBD patients and
healthy controls (Supplementary Table 1), as it was previously
reported that the two have differentmicrobiota22. The principal com-
ponent analysis, based on the same 155 species, clearly separates
patients from healthy individuals and the ulcerative colitis from
the Crohn’s disease patients (Fig. 4), confirming our hypothesis.
Functions encoded by the prevalent gene set
We classified the predicted genes by aligning them to the integrated
NCBI-NRdatabase of non-redundant protein sequences, the genes in
the KEGG (Kyoto Encyclopedia of Genes and Genomes)24 pathways,
and COG (Clusters of Orthologous Groups)25 and eggNOG26 data-
bases. There were 77.1% genes classified into phylotypes, 57.5% to
eggNOG clusters, 47.0% to KEGG orthology and 18.7% genes
assigned to KEGG pathways, respectively (Supplementary Table 9).
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Figure 3 | Relative abundance of 57 frequent microbial genomes among
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See Methods for computation.
1
Number of individuals sampled
N
um
b
er
 o
f o
rt
ho
lo
go
us
 g
ro
up
s/
ge
ne
 fa
m
ili
es
 (×
10
3 )
25 50 75 100 124
a b
c
320,000
280, 000
240,000
200,000
160,000
1.0 0.8 0.6 0.4 0.2 0
0.6
0.7
0.8
0.9
1.0
0.5
85%
90%
95%
0
5
10
15
20
0
1
2
3
4
1 20 40 60 80 100
OGs + novel gene families
Known + unknown OGs
Known OGs
N
um
b
er
 o
f n
on
-r
ed
un
d
an
t
ge
ne
s 
(×
10
6 )
N
um
b
er of target genes covered
Fr
ac
tio
n 
of
 t
ar
ge
t 
ge
ne
s
co
ve
re
d
Number of samples Fraction of gene length covered
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Almost all (99.96%) of the phylogenetically assigned genes belonged
to the Bacteria and Archaea, reflecting their predominance in the gut.
Genes that were not mapped to orthologous groups were clustered
into gene families (see Methods). To investigate the functional con-
tent of the prevalent gene set we computed the total number of
orthologous groups and/or gene families present in any combination
of n individuals (with n5 2–124; see Fig. 2c). This rarefaction ana-
lysis shows that the ‘known’ functions (annotated in eggNOG or
KEGG) quickly saturate (a value of 5,569 groups was observed): when
sampling any subset of 50 individuals, most have been detected.
However, three-quarters of the prevalent gut functionalities consists
of uncharacterized orthologous groups and/or completely novel gene
families (Fig. 2c).When including these groups, the rarefaction curve
only starts to plateau at the very end, at a much higher level (19,338
groups were detected), confirming that the extensive sampling of a
large number of individuals was necessary to capture this considerable
amount of novel/unknown functionality.
Bacterial functions important for life in the gut
The extensive non-redundant catalogue of the bacterial genes from
the human intestinal tract provides an opportunity to identify bac-
terial functions important for life in this environment. There are
functions necessary for a bacterium to thrive in a gut context (that
is, the ‘minimal gut genome’) and those involved in the homeostasis
of the whole ecosystem, encoded across many species (the ‘minimal
gut metagenome’). The first set of functions is expected to be present
in most or all gut bacterial species; the second set in most or all
individuals’ gut samples.
To identify the functions encoded by the minimal gut genome we
use the fact that they should be present in most or all gut bacterial
species and therefore appear in the gene catalogue at a frequency
above that of the functions present in only some of the gut bacterial
species. The relative frequency of different functions can be deduced
from the number of genes recruited to different eggNOG clusters,
after normalization for gene length and copy number (Supplemen-
tary Fig. 10a, b). We ranked all the clusters by gene frequencies and
determined the range that included the clusters specifying well-
known essential bacterial functions, such as those determined experi-
mentally for a well-studied firmicute, Bacillus subtilis27, hypothe-
sizing that additional clusters in this range are equally important.
As expected, the range that included most of B. subtilis essential
clusters (86%) was at the very top of the ranking order (Fig. 5).
Some 76% of the clusters with essential genes of Escherichia coli28
were within this range, confirming the validity of our approach.
This suggests that 1,244metagenomic clusters foundwithin the range
(Supplementary Table 10; termed ‘range clusters’ hereafter) specify
functions important for life in the gut.
We found two types of functions among the range clusters: those
required in all bacteria (housekeeping) and those potentially specific
for the gut. Among many examples of the first category are the
functions that are part of main metabolic pathways (for example,
central carbon metabolism, amino acid synthesis), and important
protein complexes (RNA andDNApolymerase, ATP synthase, general
secretory apparatus). Not surprisingly, projection of the range clusters
on the KEGG metabolic pathways gives a highly integrated picture of
the global gut cell metabolism (Fig. 6a).
The putative gut-specific functions include those involved in adhe-
sion to the host proteins (collagen, fibrinogen, fibronectin) or in
harvesting sugars of the globoseries glycolipids, which are carried
on blood and epithelial cells. Furthermore, 15% of range clusters
encode functions that are present in,10% of the eggNOG genomes
(see Supplementary Fig. 11) and are largely (74.3%) not defined
(Fig. 6b). Detailed studies of these should lead to a deeper compre-
hension of bacterial life in the gut.
To identify the functions encoded by theminimal gut metagenome,
we computed the orthologous groups that are shared by individuals of
our cohort. Thisminimal set, of 6,313 functions, ismuch larger than the
one estimated in a previous study8. There are only 2,069 functionally
annotated orthologous groups, showing that they gravely underesti-
mate the true size of the common functional complement among indi-
viduals (Fig. 6c). Theminimal gutmetagenome includes a considerable
fraction of functions (,45%) that are present in ,10% of the
sequenced bacterial genomes (Fig. 6c, inset). These otherwise rare func-
tionalities that are found in eachof the124 individualsmaybenecessary
for the gut ecosystem. Eighty per cent of these orthologous groups
contain genes with at best poorly characterized function, underscoring
our limited knowledge of gut functioning.
Of the known fraction, about 5% codes for (pro)phage-related
proteins, implying a universal presence and possible important eco-
logical role of bacteriophages in gut homeostasis. The most striking
secondary metabolism that seems crucial for the minimal metage-
nome relates, not unexpectedly, to biodegradation of complex sugars
and glycans harvested from the host diet and/or intestinal lining.
Examples include degradation and uptake pathways for pectin
(and its monomer, rhamnose) and sorbitol, sugars which are omni-
present in fruits and vegetables, but which are not or poorly absorbed
by humans. As some gutmicroorganisms were found to degrade both
of them29,30, this capacity seems to be selected for by the gut ecosystem
as a non-competitive source of energy. Besides these, capacity to
ferment, for example, mannose, fructose, cellulose and sucrose is also
part of the minimal metagenome. Together, these emphasize the
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strong dependence of the gut ecosystem on complex sugar degrada-
tion for its functioning.
Functional complementarities of the genome and metagenome
Detailed analysis of the complementarities between the gut metage-
nome and the human genome is beyond the scope of the present work.
To provide an overview,we considered two factors: conservation of the
functions in the minimal metagenome and presence/absence of func-
tions in one or the other (Supplementary Table 11). Gut bacteria use
mostly fermentation to generate energy, converting sugars, in part, to
short-chain fatty acid, that areusedby thehost as energy source.Acetate
is important for muscle, heart and brain cells31, propionate is used in
host hepatic neoglucogenic processes, whereas, in addition, butyrate is
important for enterocytes32. Beyond short-chain fatty acid, a number of
amino acids are indispensable to humans33 and can be provided by
bacteria34. Similarly, bacteria can contribute certain vitamins3 (for
example, biotin, phylloquinone) to the host. All of the steps of biosyn-
thesis of these molecules are encoded by the minimal metagenome.
Gut bacteria seem to be able to degrade numerous xenobiotics,
including non-modified andhalogenated aromatic compounds (Sup-
plementary Table 11), even if the steps of most pathways are not part
of theminimalmetagenome and are found in a fraction of individuals
only. A particularly interesting example is that of benzoate, which is a
common food supplement, known as E211. Its degradation by the
coenzyme-A ligation pathway, encoded in the minimal metagenome,
leads to pimeloyl-coenzyme-A, which is a precursor of biotin, indi-
cating that this food supplement can have a potentially beneficial role
for human health.
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Figure 6 | Characterization of the minimal gut genome and metagenome.
a, Projection of the minimal gut genome on the KEGG pathways using the
iPath tool38. b, Functional composition of the minimal gut genome and
metagenome. Rare and frequent refer to the presence in sequenced eggNOG
genomes. c, Estimation of the minimal gut metagenome size. Known
orthologous groups (red), known plus unknown orthologous groups (blue)
and orthologous groups plus novel gene families (.20 proteins; grey) are
shown (see Fig. 2c for definition of box and whisker plot). The inset shows
composition of the gut minimal microbiome. Large circle: classification in
the minimal metagenome according to orthologous group occurrence in
STRING739 bacterial genomes. Common (25%), uncommon (35%) and rare
(45%) refer to functions that are present in .50%, ,50% but .10%, and
,10% of STRING bacteria genomes, respectively. Small circle: composition
of the rare orthologous groups. Unknown (80%) have no annotation or are
poorly characterized, whereas known bacterial (19%) and phage-related
(1%) orthologous groups have functional description.
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Discussion
We have used extensive Illumina GA short-read-based sequencing of
total faecal DNA from a cohort of 124 individuals of European
(Nordic and Mediterranean) origin to establish a catalogue of non-
redundant human intestinal microbial genes. The catalogue contains
3.3 million microbial genes, 150-fold more than the human gene
complement, and includes an overwhelming majority (.86%) of
prevalent genes harboured by our cohort. The catalogue probably
contains a largemajority of prevalent intestinalmicrobial genes in the
human population, for the following reasons: (1) over 70% of the
metagenomic reads from three previous studies, including American
and Japanese individuals8,16,17, can be mapped on our contigs; (2)
about 80% of the microbial genes from 89 frequent gut reference
genomes are present in our set. This result represents a proof of
principle that short-read sequencing can be used to characterize
complex microbiomes.
The full bacterial gene complement of each individual was not
sampled in our work. Nevertheless, we have detected some 536,000
prevalent unique genes in each, out of the total of 3.3 million carried
by our cohort. Inevitably, the individuals largely share the genes of
the common pool. At the present depth of sequencing, we found that
almost 40% of the genes from each individual are shared with at least
half of the individuals of the cohort. Future studies of world-wide
span, envisaged within the International Human Microbiome
Consortium, will complete, as necessary, our gene catalogue and
establish boundaries to the proportion of shared genes.
Essentially all (99.1%) of the genes of our catalogue are of bacterial
origin, the remainder beingmostly archaeal, with only 0.1%of eukar-
yotic and viral origins. The gene catalogue is therefore equivalent to
that of some 1,000 bacterial species with an average-sized genome,
encoding about 3,364 non-redundant genes. We estimate that no
more than 15% of prevalent genes of our cohort may be missing
from the catalogue, and suggest that the cohort harbours no more
than,1,150 bacterial species abundant enough to be detected by our
sampling. Given the large overlap between microbial sequences in
this and previous studies we suggest that the number of abundant
intestinal bacterial species may be not much higher than that
observed in our cohort. Each individual of our cohort harbours at
least 160 such bacterial species, as estimated by the average prevalent
gene number, and many must thus be shared.
We assigned about 12% of the reference set genes (404,000) to the
194 sequenced intestinal bacterial genomes, and can thus associate
them with bacterial species. Sequencing of at least 1,000 human-
associated bacterial genomes is foreseen within the International
Human Microbiome Consortium, via the Human Microbiome
Project and MetaHIT. This is commensurate with the number of
dominant species in our cohort and expectedmore broadly in human
gut, and should enable a muchmore extensive gene to species assign-
ment. Nevertheless, we used the presently available sequenced
genomes to explore further the concept of largely shared species
among our cohort and identified 75 species common to .50% of
individuals and 57 species common to .90%. These numbers are
likely to increase with the number of sequenced reference strains and
a deeper sampling. Indeed, a 2–3-fold increase in sequencing depth
raised by 25% the number of species that we could detect as shared
between two individuals. A large number of shared species supports
the view that the prevalent human microbiome is of a finite and not
overly large size.
How can this view be reconciled with that of a considerable inter-
personal diversity of innumerable bacterial species in the gut, arising
from most previous studies using the 16S RNA marker gene4,8,10,11?
Possibly the depth of sampling of these studies was insufficient to
reveal common species when present at low abundance, and empha-
sized the difference in the composition of a relatively few dominant
species. We found a very high variability of abundance (12- to 2,200-
fold) for the 57 most common species across the individuals of our
cohort. Nevertheless, a recent 16S rRNA-based study concluded that
a common bacterial species ‘core’, shared among at least 50% of
individuals under study, exists35.
Detailed comparisons of bacterial genes across the individuals of
our cohort will be carried out in the future, within the context of
the ongoing MetaHIT clinical studies of which they are part.
Nevertheless, clustering of the genes in families allowed us to capture
a virtually full functional potential of the prevalent gene set and
revealed a considerable novelty, extending the functional categories
by some 30% in regard to previous work8. Similarly, this analysis has
revealed a functional core, conserved in each individual of the cohort,
which reflects the full minimal human gut metagenome, encoded
acrossmany species and probably required for the proper functioning
of the gut ecosystem. The size of this minimal metagenome exceeds
several-fold that of the core metagenome reported previously8. It
includes functions known to be important to the host–bacterial inter-
action, such as degradation of complex polysaccharides, synthesis of
short-chain fatty acids, indispensable amino acids and vitamins.
Finally, we also identified functions that we attribute to a minimal
gut bacterial genome, likely to be required by any bacterium to thrive
in this ecosystem. Besides general housekeeping functions, the
minimal genome encompassesmany genes of unknown function, rare
in sequenced genomes and possibly specifically required in the gut.
Beyond providing the global view of the human gut microbiome,
the extensive gene cataloguewe have established enables future studies
of association of the microbial genes with human phenotypes and,
even more broadly, human living habits, taking into account the
environment, including diet, from birth to old age.We anticipate that
these studies will lead to a much more complete understanding of
human biology than the one we presently have.
METHODS SUMMARY
Human faecal samples were collected, frozen immediately andDNAwas purified
by standard methods22. For all 124 individuals, paired-end libraries were con-
structed with different clone insert sizes and subjected to Illumina GA sequen-
cing. All reads were assembled using SOAPdenovo19, with specific parameter
‘2M 3’ for metagenomics data. MetaGene was used for gene prediction. A
non-redundant gene set was constructed by pair-wise comparison of all genes,
using BLAT36 under the criteria of identity .95% and overlap .90%. Gene
taxonomic assignments were made on the basis of BLASTP37 search (e-value
,13 1025) of the NCBI-NR database and 126 known gut bacteria genomes.
Gene functional annotations were made by BLASTP search (e-value,13 1025)
with eggNOG and KEGG (v48.2) databases. The total and shared number of
orthologous groups and/or gene families were computed using a random com-
bination of n individuals (with n5 2 to 124, 100 replicates per bin).
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Human faecal sample collection. Danish individuals were from the Inter-99
cohort40, varying in phenotypes according to BMI and status towards obesity/
diabetes, whereas Spanish individuals were either healthy controls or patients
with chronic inflammatory bowel diseases (Crohn’s disease or ulcerative colitis)
in clinical remission.
Patients and healthy controls were asked to provide a frozen stool sample.
Fresh stool samples were obtained at home, and samples were immediately
frozen by storing them in their home freezer. Frozen samples were delivered
to the Hospital using insulating polystyrene foam containers, and then they were
stored at 280 uC until analysis.
DNA extraction.A frozen aliquot (200mg) of each faecal sample was suspended
in 250ml of guanidine thiocyanate, 0.1M Tris (pH 7.5) and 40ml of 10%
N-lauroyl sarcosine. Then, DNA extraction was conducted as previously
described22. The DNA concentration and its molecular size were estimated by
nanodrop (Thermo Scientific) and agarose gel electrophoresis.
DNA library construction and sequencing. DNA library preparation followed
the manufacturer’s instruction (Illumina). We used the same workflow as
described elsewhere to perform cluster generation, template hybridization, iso-
thermal amplification, linearization, blocking and denaturization and hybridi-
zation of the sequencing primers. The base-calling pipeline (version
IlluminaPipeline-0.3) was used to process the raw fluorescent images and call
sequences.
We constructed one library (clone insert size 200 bp) for each of the first 15
samples, and two libraries with different clone insert sizes (135 bp and 400bp) for
each of the remaining 109 samples for validation of experimental reproducibility.
To estimate the optimal return between the generation of novel sequence and
sequencing depth, we aligned the Illumina GA reads from samples MH0006 and
MH0012 onto 468,335 Sanger reads totalling to 311.7Mb generated from the
same two samples (156.9 and 154.7Mb, respectively, Supplementary Table 2),
using the Short Oligonucleotide Alignment Program (SOAP)41 and a match
requirement of 95% sequence identity. With about 4Gb of Illumina sequence,
94% and 89% of the Sanger reads (forMH0006 andMH0012, respectively) were
covered. Further extensive sequencing, to 12.6 and 16.6Gb for MH0006 and
MH0012, respectively, brought only a moderate increase of coverage to about
95% (Supplementary Fig. 1).More than 90%of the Sanger reads were covered by
the Illumina sequences to a very high and uniform level (Supplementary Fig. 2),
indicating that there is little or no bias in the Illumina GA sequence. As expected,
a large proportion of Illumina sequences (57% and 74% for M0006 and M0012,
respectively) was novel and could not be mapped onto the Sanger reads. This
fraction was similar at the 4 and 12–16Gb sequencing levels, confirming that
most of the novelty was captured already at 4Gb.
We generated 35.4–97.6 million reads for the remaining 122 samples, with an
average of 62.5 million reads. Sequencing read length of the first batch of 15
samples was 44 bp and the second batch was 75 bp.
Public data used.The sequenced bacteria genomes (totally 806 genomes) deposited
inGenBankweredownloaded fromNCBIdatabase (http://www.ncbi.nlm.nih.gov/)
on 10 January 2009. The known human gut bacteria genome sequences were down-
loaded from HMP database (http://www.hmpdacc-resources.org/cgi-bin/hmp_
catalog/main.cgi), GenBank (67 genomes), Washington University in St Louis (85
genomes, version April 2009, http://genome.wustl.edu/pub/organism/Microbes/
Human_Gut_Microbiome/), and sequenced by theMetaHIT project (17 genomes,
version September 2009, http://www.sanger.ac.uk/pathogens/metahit/). The other
gutmetagenomedata used in this project include: (1) humangutmetagenomic data
sequenced from US individuals8, which was downloaded from NCBI with the
accession SRA002775; (2) human gut metagenomic data from Japanese indivi-
duals17, which was downloaded from P. Bork’s group at EMBL (http://www.
bork.embl.de). The integrated NR database we constructed in this study included
NCBI-NR database (version April 2009) and all genes from the known human gut
bacteria genomes.
Illumina GA short reads de novo assembly. High-quality short reads of each
DNA sample were assembled by the SOAPdenovo assembler19. In brief, we first
filtered the low abundant sequences from the assembly according to 17-mer fre-
quencies. The 17-merswithdepth less than5were screened in front of assembly, for
these low-frequency sequences were very unlikely to be assembled, whereas remov-
ing them would significantly reduce memory requirement and make assembly
feasible in an ordinary supercomputer (512GB memory in our institute).
Then the sequences were processed one by one and the de Bruijn graph data
format was used to store the overlap information among the sequences. The
overlap paths supported by a single read were unreliable and removed. Short
low-depth tips and bubbles that were caused by sequencing errors or genetic
variations between microbial strains were trimmed and merged, respectively.
Read paths were used to solve the tiny repeats.
Finally, we broke the connections at repeat boundaries, and outputted the
continuous sequences with unambiguous connections as contigs. The metage-
nomic specialmodel was chosen, and parameters ‘2K 21’ and ‘2K 23’ were used
for 44 bp and 75 bp reads, respectively, to indicate the minimal sequence overlap
required.
After de novo assembly for each sample independently, we merged all the
unassembled reads together and performed assembly for them, as to maximize
the usage of data and assemble themicrobial genomes that have low frequency in
each read set, but have sufficient sequence depth for assembly by putting the data
of all samples together.
Validating Illumina contigs using Sanger reads. We used BLASTN (WU-
BLAST 2.0) to map Sanger reads from samples MH0006 and MH0012
(156.9Mb and 154.7Mb, respectively) to Illumina contigs (single best hit longer
than 75 bp and over 95% identity) from the same samples. Each alignment was
scanned for breakage of collinearity where both sequences have at least 50 bases
left unaligned at one end of the alignment. Each such breakage was considered an
assembly error in the Illumina contig at the location where collinearity breaks.
Errors within 30 bp from each other weremerged. An error was discarded if there
exists a Sanger read that agrees with the contig structure for 60 bp on both sides
of the error. For comparison, we repeated this on a Newbler2 assembly of 454
Titanium reads fromMH0006 (550Mb reads). Supplementary Fig. 5a shows the
number of errors per Mb of assembled Illumina/454 contigs. We estimate 14.12
errors per Mb of contigs for the Illumina assembly, which is comparable to that
of the 454 assembly (20.73 per Mb). 98.7% of Illumina contigs that map at least
one Sanger read were collinear over 99.55% of the mapped regions, which is
comparable to 97.86% of such 454 contigs being collinear over 99.48% of the
mapped regions.
Evaluation of human gut microbiome coverage. The Illumina GA reads were
aligned against the assembled contigs and known bacteria genomes using
SOAP41 by allowing at most two mismatches in the first 35-bp region and
90% identity over the read sequence. The Roche/454 and Sanger sequencing
reads were aligned against the same reference using BLASTN with 13 1028,
over 100 bp alignment length andminimal 90% identity cutoff. Twomismatches
were allowed and identity was set 95% over the read sequence when aligned to
the GA reads ofMH0006 andMH0012 to Sanger reads from the same samples by
SOAP.
Gene prediction and construction of the non-redundant gene set. We use
MetaGene20—which uses di-codon frequencies estimated by the GC content
of a given sequence, and predicts a whole range ofORFs based on the anonymous
genomic sequences—to findORFs from the contigs of each of the 124 samples as
well as the contigs from the merged assembly.
The predicted ORFs were then aligned to each other using BLAT36. A pair of
genes with greater than 95% identity and aligned length covered over 90% of the
shorter gene was grouped together. The groups sharing genes were then merged,
and the longestORF in eachmerged groupwas used to represent the group, and the
othermembers of the groupwere takenas redundancy. Therefore, we organized the
non-redundant gene set from all the predicted genes by excluding the redundancy.
Finally, theORFswith length less than 100bpwere filtered.We translated theORFs
into protein sequences using the NCBI Genetic Codes11.
Identification of genes. To make a balance between identifying low-abundance
genes and reducing the error-rate of identification, we explored the impact of the
threshold set for read coverage required to identify a gene in individual micro-
biomes. The number of genes decreased about twice when the number of reads
required for identification was increased from 2 to 6, and changed slowly there-
after (Supplementary Fig. 6a). Nevertheless, to include the rare genes into the
analysis, we selected the threshold of 2 reads.
Gene taxonomic assignment. Taxonomic assignment of predicted genes was
carried out using BLASTP alignment against the integrated NR database.
BLASTP alignment hits with e-values larger than 13 1025 were filtered, and for
each gene the significantmatches whichwere defined by e-values#103 e-value of
the tophitwere retained todistinguish taxonomic groups.Thenwedetermined the
taxonomical level of each gene by the lowest common ancestor (LCA)-based
algorithm that was implemented in MEGAN42. The LCA-based algorithm assigns
genes to taxa in the way that the taxonomical level of the assigned taxon reflects the
level of conservation of the gene. For example, if a gene was conserved in many
species, it was assigned to the LCA rather than to a species.
Gene functional classification. We used BLASTP to search the protein
sequences of the predicted genes in the eggNOGdatabase26 andKEGGdatabase24
with e-value#13 1025. The genes were annotated as the function of the NOGs
or KEGG homologues with lowest e-value. The eggNOG database is an integ-
ration of the COG and KOG databases. The genes annotated by COG were
classified into the 25 COG categories, and genes that were annotated by KEGG
were assigned into KEGG pathways.
doi:10.1038/nature08821
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Determinationofminimal gut bacterial genome.Thenumber of non-redundant
genes assigned to the eggNOG clusters was normalized by gene length and cluster
copynumber (SupplementaryFig. 8). The clusterswere rankedbynormalized gene
number and the range that included the clusters encoding essentialBacillus subtilis
genes was determined, computing the proportion of these clusters among the
successive groups of 100 clusters. Analysis of the range gene clusters involved,
besides iPath projections, use of KEGG and manual verification of the complete-
ness of the pathways and protein machineries they encode.
Determination of total functional complement and minimal metagenome.
We computed the total and shared number of orthologous groups and/or gene
families present in random combinations of n individuals (with n5 2 to 124, 100
replicates per bin). This analysis was performed on three groups of gene clusters:
(1) known eggNOG orthologous groups (that is, those with functional annota-
tion, excluding those in which the terms [Uu]ncharacteri[sz]ed, [Uu]nknown,
[Pp]redicted or[Pp]utative occurred); (2) all eggNOG orthologous groups; (3)
all orthologous groups plus gene families constructed from remaining genes not
assigned to the two above categories. Families were clustered from all-against-all
BLASTP results usingMCL43 with an inflation factor of 1.1 and a bit-score cutoff
of 60.
Rarefaction analysis. Estimation of total gene richness was done using
EstimateS on 100 randomly picked samples due to memory limitations.
Because the CV value was.0.5, both chao2 (classic) and ICE richness estimators
were calculated and the larger estimate of the two (ICE) was used. The estimate
for this sample size was 3,621,646 genes (ICE) whereas Sobs (Mao Tau) was
3,090,575 genes, or 85.3%. The ICE estimator curve did not completely saturate,
(data not shown) indicating that additional samples will need to be added to
achieve a final, conclusive estimate.
Common bacterial core. To eliminate the influence of very similar strains and
assess the presence of known microbial species among the individuals of the
cohort, we used 650 sequenced bacterial and archaeal genomes as a reference set.
The set was composed from 932 publicly available genomes, whichwere grouped
by similarity, using a 90% identity cutoff and the similarity over at least 80% of
the length. From each group only the largest genome was used. Illumina reads
from 124 individuals were mapped to the set, for species profiling analysis and
the genomes originating from the same species (by differing in size .20%)
curated by manual inspection and by using the 16S-based clustering when the
sequences were available.
Relative abundance of microbial genomes among individuals.We computed
the genome coverage by uniquely mapping Illumina reads and normalized it to
1Gb of sequence, to correct for different sequencing levels in different indivi-
duals. The coverage was summed over all species of the non-redundant bacterial
genome set for each individual and the proportion of each species relative to the
sum calculated.
Species co-existence network. For the 155 species that had genome coverage by
the Illumina reads$1% in at least one individual we calculated the pair-wise
inter-species Pearson correlations between sequencing depths (abundance)
throughout the entire cohort of 124 individuals. From the resulting 11,175
inter-species correlations, correlations less than 20.4 or above 0.4 (n5 342)
were visualized in a graph using Cytoscape44 displaying the average genome
coverage of each species as node size in the graph.
40. Toft, U. et al. The impact of a population-based multi-factorial lifestyle
intervention on changes in long-term dietary habits: The Inter99 study. Prev. Med.
47, 378–383 (2008).
41. Li, R. et al. SOAP2: an improved ultrafast tool for short read alignment.
Bioinformatics 25, 1966–1967 (2009).
42. Huson, D. H., Auch, A. F., Qi, J. & Schuster, S. C.MEGAN analysis of metagenomic
data. Genome Res. 17, 377–386 (2007).
43. vanDongen, S.GraphClustering by FlowSimulation. PhD thesis,Univ.Utrecht (2000).
44. Shannon, P. et al. Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
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3.2 Article 2: “Enterotypes of the human gut micro-
biome”
The Human Microbiome Project was launched in 2008 with the goal of identifying
and characterising microorganisms associated with disease. The importance of the
human gut microbiome to the host has been demonstrated by many studies describ-
ing the influence of the microbiome on gut development, the immune system, and
even behaviour. Moreover, the transplant of microbiota from healthy individuals
to IBD patients has led to unexpected positive results, thus supporting the impor-
tance of the gut microbiome for human health and indicating a possible division of
so-called ‘good’ and ‘bad’ bacteria. The identification of bad bacteria could reveal
the aetiology of many gut-related diseases, leading to the development of new drugs.
However, the search for the ‘healthy microbiome’ is difficult, because many factors,
including lifestyle, genotype, age, physiology, pathobiology, the environment, and
immunity, influence the gut microbiome. Thus, we expected that individuals with
the same genotype would be more likely than unrelated individuals would to have
a similar gut microbiome. Moreover, the microbiome of individuals from the same
country would likely be more similar than that between individuals from different
countries owing to similarities in lifestyle and diet. Indeed, diet was expected to
have a large impact on the human gut microbiome. However, because these factors
were expectations based primarily on intuition rather than on specific knowledge
of the relationships, researchers attempted to demonstrate which factors were most
important in determining gut microbiome composition. Surprisingly, none of these
factors was found to exert a strong enough influence to explain the variation of the
human gut microbiome and its link to disease. Analysis of patients was considered
as a better strategy for determining what constitutes healthy and unhealthy micro-
biomes. Therefore, the new goal of researchers was to find one or a few bacteria that
could be the cause of disease. Previous articles had shown the importance of two
phyla, Bacteroidetes and Firmicutes, of which Bacteroidetes has the highest vari-
ance in relative abundance. Moreover, the B/F ratio may be important for the gut
microbiome, as 90% of the relative abundance of all samples is composed of Bac-
teroidetes and Firmicutes. Thus, while many groups were testing various factors
of influence or looking for bacterial markers to explain variations in the gut micro-
biome, the MetaHIT consortium was doing the opposite. Peer Bork and co-workers,
for example, have conducted studies to identify the main driving force behind the
gut microbiome by analysing variance in the data. The publication of ‘Enterotypes
of the human gut microbiome’ had a major impact on the field. For the first time,
factors previously identified as influential in gut composition were demonstrated to
have no effect on human gut microbiome variation. Factors such as body mass index,
age, gender, nation, or continent could not explain the three robust clusters found
in the data. Although the article offered no biological explanation for the cause of
the data separation, it had a significant impact on the scientific view of the human
gut microbiome. The article redefined the direction of research in the field, as the
main factor in gut composition and variation, although of unknown cause, was now
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clear and present in any microbiome dataset. The three clusters (Figure 3.2), called
enterotypes, were confirmed by microarray results, showing that the results are con-
sistent between technologies and reproducible. My work in this study was to develop
a microarray chip, which could profile any human gut microbiome. Using the gene
catalogue described in article one, I designed a microarray chip using 700,000 genes
— the first microarray capable of profiling genes from the human gut microbiome.
The 700,000 genes can represent 60% (Gut-Array V.4) to 80% (Gut-Array V.5) of the
sequencing data from more than 600 samples, and the microarray has the versatility
to profile DNA and RNA samples, overcoming the rRNA challenges in RNA sample
sequencing. Using Gut-Array V.4, we profiled the samples used in the published
paper, and I performed the analysis to find the clusters using the same methodology
described in the paper. To perform the analysis, I developed a taxonomy pipeline
to profile the high number of genes. This pipeline was used in the current article
and in the third article, below. Moreover, to find the genus abundance used in the
enterotypes study, I developed a package in ‘R’ to work with metagenomic data. To
find genus abundance, I used the same methodology as that applied to find the clus-
ters using the microarray samples. The results confirmed the three robust clusters
dominated by Bacteroides, Prevotella, and Ruminococcus found in the sequencing
data by Peer Bork and co-workers.
Figure 3.2: Abundance of the three main contributors for each enterotype. Figure
from [58] as figure 2d. This figure is important as it shows not only the three
main groups found in the human gut microbiome distribution, but also demonstrate
the difference in diversity among the three groups. Prevotella group has the most
uneven distribution. Ruminococcus with the most even distribution and the lowest
relative abundance, suggesting high richness. Bacteroides average level of evenness
but overall high relative abundance for the three groups, suggesting low richness.
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Enterotypes of thehumangutmicrobiome
Manimozhiyan Arumugam1*, Jeroen Raes1,2*, Eric Pelletier3,4,5, Denis Le Paslier3,4,5, Takuji Yamada1, Daniel R. Mende1,
Gabriel R. Fernandes1,6, Julien Tap1,7, Thomas Bruls3,4,5, Jean-Michel Batto7, Marcelo Bertalan8, Natalia Borruel9,
Francesc Casellas9, Leyden Fernandez10, Laurent Gautier8, Torben Hansen11,12, Masahira Hattori13, Tetsuya Hayashi14,
Michiel Kleerebezem15, Ken Kurokawa16, Marion Leclerc7, Florence Levenez7, Chaysavanh Manichanh9, H. Bjørn Nielsen8,
Trine Nielsen11, Nicolas Pons7, Julie Poulain3, Junjie Qin17, Thomas Sicheritz-Ponten8,18, Sebastian Tims15, David Torrents10,19,
Edgardo Ugarte3, Erwin G. Zoetendal15, Jun Wang17,20, Francisco Guarner9, Oluf Pedersen11,21,22,23, Willem M. de Vos15,24,
Søren Brunak8, Joel Dore´7, MetaHIT Consortium{, Jean Weissenbach3,4,5, S. Dusko Ehrlich7 & Peer Bork1,25
Our knowledge of species and functional composition of the human gut microbiome is rapidly increasing, but it is still
based on very few cohorts and little is known about variation across theworld. By combining 22 newly sequenced faecal
metagenomes of individuals from four countries with previously published data sets, here we identify three robust
clusters (referred to as enterotypes hereafter) that are not nation or continent specific. We also confirmed the
enterotypes in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not
continuous. This indicates further the existence of a limited number of well-balanced host–microbial symbiotic states
that might respond differently to diet and drug intake. The enterotypes are mostly driven by species composition, but
abundant molecular functions are not necessarily provided by abundant species, highlighting the importance of a
functional analysis to understand microbial communities. Although individual host properties such as body mass
index, age, or gender cannot explain the observed enterotypes, data-driven marker genes or functional modules can
be identified for each of these host properties. For example, twelve genes significantly correlate with age and three
functional modules with the body mass index, hinting at a diagnostic potential of microbial markers.
Various studies of the human intestinal tract microbiome based on
the 16S ribosomal-RNA-encoding gene reported species diversity
within and between individuals1–3, and the first metagenomics studies
characterized the functional repertoire of the microbiomes of several
American4,5 and Japanese6 individuals. Although a general consensus
about the phylum level composition in the human gut is emerging1,3,7,
the variation in species composition1,2 and gene pools5,8 within the
human population is less clear. Furthermore, it is unknown whether
inter-individual variation manifests itself as a continuum of different
community compositions or whether individual gut microbiota con-
gregate around preferred, balanced and stable community composi-
tions that can be classified. Studying such questions is complicated by
the complexity of sampling, DNA preparation, processing, sequen-
cing and analysis protocols9 as well as by varying physiological, nutri-
tional and environmental conditions. To analyse the feasibility of
comparative metagenomics of the human gut across cohorts and
protocols and to obtain first insights into commonalities and differ-
ences between gut microbiomes across different populations, we
Sanger-sequenced 22 European metagenomes from Danish, French,
Italian and Spanish individuals that were selected for diversity (Sup-
plementaryNotes section 1), and combined themwith existing Sanger
(13 Japanese6, 2 American4) and pyrosequencing (2 American5) gut
data sets—totalling 39 individuals.
Global variation of human gut metagenomes
The vast majority of sequences in the newly sequenced 22 European
samples belong to bacteria—only 0.14% of the reads could be classified
as human contamination, all other eukaryotes together only comprised
0.5%, archaea 0.8% and viruses up to 5.8% (see Supplementary Notes
section 2.1 for details).
To investigate the phylogenetic composition of the 39 samples from 6
nationalities, we mapped metagenomic reads, using DNA sequence
homology, to 1,511 reference genomes (Supplementary Table 3) includ-
ing 379 publicly available human microbiome genomes generated
through the National Institutes of Health (NIH) Human Microbiome
Project10 and the European MetaHIT consortium11 (Supplementary
Methods section 4.1). To consistently estimate the functional composi-
tion of the samples, we annotated the predicted genes from the meta-
genomesusing eggNOG12orthologous groups (SupplementaryMethods
section 6.2). We ensured that comparative analysis using these proce-
dures was not biased by data-set origin, sample preparation, sequencing
technology and quality filtering (see Supplementary Notes section 1).
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We also investigated whether the relatively low and somewhat arbitrary
amounts of sequence per sample (between 53–295Mb) bias our results:
we assigned habitat information to 1,368 of the 1,511 reference
genomes, distinguished between orthologous groups from gut and
‘non-gut’ species and conclude that our data set captures most of the
functions from gut species even though functions from non-gut species
accumulated with each additional sample (Fig. 1a; see Supplementary
Notes section 1.3).
We then characterized the phylogenetic variation across samples at
the genus and phylum levels, and functional variation at gene and
functional class levels.As infants are known tohaveveryheterogeneous,
unstable and distinctive microbiota6,13, we excluded the four respective
Japanese samples from the analysis. Using calibrated similarity cutoffs
(Supplementary Fig. 1), on average, 52.8% of the fragments in each
sample could be robustly assigned to a genus in our reference genome
set (ranging from 22% to 80.5%), and 80% could be assigned to a
phylum(ranging from64.9% to 91%) implying that the trends observed
(Fig. 1b) represent a large fraction of the metagenome.
The phylogenetic composition of the newly sequenced samples
confirms that the Firmicutes and Bacteroidetes phyla constitute the
vast majority of the dominant human gut microbiota7 (Fig. 1b, inset).
Bacteroides was the most abundant but also most variable genus
across samples (Fig. 1b and Supplementary Notes section 2.2), agree-
ing with previous observations6,14. Our function identification pro-
tocol led to a high functional assignment rate: 63.5% of all predicted
genes in the Sanger-sequenced samples analysed (41% of all predicted
genes in two samples obtained by pyrosequencing; Supplementary
Table 5) can be assigned to orthologous groups, and orthologous
group abundance patterns agree with previous observations6,15 (for
example, histidine kinases make up the largest group; Fig. 1c and
Supplementary Notes section 2.3).
Abundant functions from low-abundance microbes
Microbes in the human gut undergo selective pressure from the host as
well as frommicrobial competitors. This typically leads to a homeostasis
of the ecosystem in which some species occur in high and many in low
abundance16 (the ‘long-tail’ effect, as seen in Fig. 1b), with some low-
abundance species, like methanogens17, performing specialized func-
tions beneficial to the host. Metagenomics enables us to study the
presence of abundant functions shared by several low-abundance
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Figure 1 | Functional and phylogenetic profiles of human gut microbiome.
a, Simulationof the detection of distinct orthologous groupswhen increasing the
number of individuals (samples). Complete genomes were classified by habitat
information and the orthologous groups divided into those that occur in known
gut species (red) and those that have not yet been associatedwith gut (blue). The
former are close to saturation when sampling 35 individuals (excluding infants)
whereas functions from non-gut (probably rare and transient) species are not.
b, Genus abundance variation box plot for the 30 most abundant genera as
determined by read abundance. Genera are coloured by their respective phylum
(see inset for colour key). Inset shows phylum abundance box plot. Genus and
phylum level abundances were measured using reference-genome-based
mapping with 85% and 65% sequence similarity cutoffs. Unclassified genera
under a higher rank are marked by asterisks. c, Orthologous group abundance
variation box plot for the 30 most abundant orthologous gruops as determined
by assignment to eggNOG12. Orthologous groups are coloured by their
respective functional category (see inset for colour key). Inset shows abundance
box plot of 24 functional categories. Boxes represent the interquartile range
(IQR) between first and third quartiles and the line inside represents themedian.
Whiskers denote the lowest and highest values within 1.53 IQR from the first
and third quartiles, respectively. Circles represent outliers beyond the whiskers.
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species, which could shed light on their survival strategies in the
humangut. In the samples analysedhere, themost abundantmolecular
functions generally trace back to themost dominant species. However,
we identified some abundant orthologous groups that are contributed
to primarily by low-abundance genera (see Supplementary Fig. 2, Sup-
plementary Table 6 and Supplementary Notes section 3). For example,
low-abundance Escherichia contribute over 90% of two abundant
proteins associated with bacterial pilus assembly, FimA (COG3539)
and PapC (COG3188), found in one individual (IT-AD-5). Pili enable
the microbes to colonize the epithelium of specific host organs; they
helpmicrobes to stay longer in the human intestinal tract by binding to
human mucus or mannose sugars present on intestinal surface struc-
tures18. They are also key components in the transfer of plasmids
between bacteria through conjugation, often leading to exchange of
protective functions such as antibiotic resistance18. Pili can thus pro-
videmultiple benefits to these low-abundancemicrobes in their efforts
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Figure 2 | Phylogenetic differences between enterotypes. a–c, Between-class
analysis, which visualizes results from PCA and clustering, of the genus
compositions of 33 Sanger metagenomes estimated by mapping the
metagenome reads to 1,511 reference genome sequences using an 85%
similarity threshold (a), Danish subset containing 85 metagenomes from a
published Illumina data set8 (b) and 154 pyrosequencing-based 16S sequences5
(c) reveal three robust clusters that we call enterotypes. IBD, inflammatory
bowel disease. Two principal components are plotted using the ade4 package in
R with each sample represented by a filled circle. The centre of gravity for each
cluster is marked by a rectangle and the coloured ellipse covers 67% of the
samples belonging to the cluster. IBD, inflammatory bowel disease.
d, Abundances of the main contributors of each enterotype from the Sanger
metagenomes. See Fig. 1 for definition of box plot. e, Co-occurrence networks
of the three enterotypes from the Sanger metagenomes. Unclassified genera
under a higher rank are marked by asterisks in b and e.
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to survive and persist in the human gut. This example illustrates that
abundant species or genera cannot reveal the entire functional com-
plexity of the gut microbiota. More reference genomes will facilitate
better taxonomic assignment from samples and thus the detection of
more low-abundance species. However, there is not much room for
as yet undetected, abundant genera. Even with our limited genus
assignment rate of 52.8% of all reads, we estimate that wemiss another
30.7% of the already classified genera owing to our strict assignment
criteria (Supplementary Fig. 1); that is, only 16.5% of all reads are likely
to belong to hitherto unknown genera.
Detection of enterotypes, cross-national clusters
To get an overview of species variation we used phylogenetic profile
similarities obtained by mapping metagenomic reads to the 1,511
reference genomes (Fig. 2a; see Supplementary Methods section 4.1).
We excluded the two American Sanger-sequenced samples4 from
further analysis because of an unusual, very low fraction of
Bacteroidetes and suspected technical artefacts19. Multidimensional
cluster analysis and principal component analysis (PCA) revealed that
the remaining 33 samples formed three distinct clusters that we desi-
gnate as enterotypes (see Supplementary Notes section 4.1, Sup-
plementary Fig. 3a and Supplementary Table 8). Each of these three
enterotypes are identifiable by the variation in the levels of one of three
genera: Bacteroides (enterotype 1), Prevotella (enterotype 2) and
Ruminococcus (enterotype 3) (Fig. 2a, d), which was reproduced using
independent array-based HITChip20 data in a subset of 22 European
samples (Supplementary Fig. 4 and Supplementary Notes section 4.5).
The same analysis on two larger published gut microbiome data sets of
different origins (16S pyrosequencing data from 154 American indivi-
duals5 and Illumina-based metagenomics data from 85 Danish indivi-
duals8; Supplementary Methods section 5) shows that these data sets
could also be represented best by three clusters (Supplementary Fig. 3b,
c and Supplementary Tables 9, 10). Two of these are also driven by
Bacteroides and Prevotella, whereas the third cluster is mostly driven by
related groups of the order Clostridiales, Blautia and unclassified
Lachnospiraceae in the 16S rDNA and Illumina data, respectively
(Fig. 2b, c). This can be explained by a different reference data set in the
instanceofthe16SrDNAdata,differentmappingbehaviourofshortreads
in the case of the Illumina data or current taxonomic uncertainties in
the Lachnospiraceae and Ruminococcaceae clades (see Supplementary
Notes section 4.2). The differences might also hint at community sub-
populationswithin this enterotype,whichmight onlybedetectablewith
substantially more samples. Correlation analysis of the Sanger data
revealed that abundances of each of the three discriminating genera
strongly correlate (that is, they co-occur or avoid each other)with those
of other genera (Fig. 2d; see Supplementary Methods section 11), indi-
cating that the enterotypes are in fact driven by groups of species that
together contribute to the preferred community compositions.
We demonstrate further the robustness of the enterotypes using
two distinct statistical concepts. First, we used the silhouette coef-
ficient21 to validate that the three clusters are superior to clusterings
obtained from various randomizations of the genus profile data,
indicating a potential role for the interactions between co-occurring
genera (see Supplementary Fig. 5 and Supplementary Notes section
4.3). Second, we used supervised learning and cross-validation to
establish that these clusters have non-random characteristics that
can be modelled and subsequently used to classify new samples
(learning on clusters from randomized genus profiles led to con-
siderably worse classification performance; see Supplementary Fig. 6
and Supplementary Notes section 4.4). These consistent results indi-
cate that enterotypes will be identifiable in human gut metagenomes
also from larger cohorts.
We then clustered the 33 samples using apurely functionalmetric: the
abundance of the assigned orthologous groups (Fig. 3a). Remarkably,
this clustering also showed a similar grouping of the samples with only
minor differences (five samples placed in different clusters compared
to Fig. 2a), indicating that function and species composition roughly
coincide with some exceptions such as Spanish sample ES-AD-3,
whose genus composition belongs to enterotype 2 whereas its func-
tional composition is similar to members of enterotype 1. This indi-
vidual has high levels of phage-related genes compared to the other
samples (see Supplementary Fig. 7), hinting at partial temporal vari-
ability and dynamics of the microbiota, and perhaps indicating phage
or virus bursts.
The robustness and predictability of the enterotypes in different
cohorts and at multiple phylogenetic and functional levels indicates
that they are the result of well-balanced, defined microbial community
compositions of which only a limited number exist across individuals.
These enterotypes are not as sharply delimited as, for example, human
blood groups; they are, in contrast, densely populated areas in a multi-
dimensional space of community composition. They are nevertheless
likely to characterize individuals, in line with previous reports that gut
a
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microbiota are quite stable in individuals and can even be restored after
perturbation22–25.
Variation between enterotypes
To determine the phylogenetic and functional basis of the entero-
types, we investigated in detail their differences in composition at
the phylum, genus, gene and pathway level as well as correlations in
abundance of co-occurring genera (Figs 2, 3; also see Supplementary
Methods sections10, 11 and12). Enterotype 1, containing eight samples,
is enriched in Bacteroides (P, 0.01; Supplementary Fig. 8), which co-
occurs, for example, with Parabacteroides (see Supplementary Table 11
for enriched genera andFig. 2e for correlationnetworks of co-occurring
genera in each enterotype). Thedrivers of this enterotype seem toderive
energy primarily from carbohydrates and proteins through fermenta-
tion, as these closely related genera have a very broad saccharolytic
potential26 and because genes encoding enzymes involved in the degra-
dation of these substrates (galactosidases, hexosaminidases, proteases)
along with glycolysis and pentose phosphate pathways are enriched in
this enterotype (see Supplementary Tables 12, 13). Enterotype 2 con-
tains six samples and is enriched in Prevotella (P, 0.01; Supplemen-
tary Fig. 9) and the co-occurring Desulfovibrio, which can act in
synergy to degrade mucin glycoproteins present in the mucosal layer
of the gut:Prevotella is a knownmucin-degrader andDesulfovibriomay
enhance the rate-limiting mucin desulphation step by removing the
sulphate27. Enterotype 3 is the most frequent and is enriched in
Ruminococcus (P, 0.01; Supplementary Fig. 10) aswell as co-occurring
Akkermansia, both knownto comprise species able to degrademucins28.
It is also enriched in membrane transporters, mostly of sugars, indi-
cating the efficient binding of mucin and its subsequent hydrolysis
as well as uptake of the resulting simple sugars by these genera.
The enriched genera indicate that enterotypes use different routes to
generate energy from fermentable substrates available in the colon,
reminiscent of a potential specialization in ecological niches or guilds.
In addition to the conversion of complex carbohydrates into absorb-
able substrates, the gut microbiota is also beneficial to the human host
by producing vitamins. Although all the vitamin metabolism path-
ways are represented in all samples, enterotypes 1 and 2 were enriched
in biosynthesis of different vitamins: biotin (Fig. 3b), riboflavin, pan-
tothenate and ascorbate in the former, and thiamine (Fig. 3c) and
folate in the latter. These phylogenetic and functional differences
among enterotypes thus reflect different combinations of microbial
trophic chains with a probable impact on synergistic interrelations
with the human hosts.
Functional biomarkers for host properties
Enterotypes do not seem to differ in functional richness (Supplemen-
tary Fig. 11), and virtually none of several measured host properties,
namely nationality, gender, age or body mass index (BMI), signifi-
cantly correlates with the enterotypes (with the exception of entero-
type 1, which is enriched in Japanese individuals). However, some
strong correlations do occur between host properties and particular
functions, at the genes ormodule level (amodule is a part of a pathway
that is functionally tightly interconnected; see Supplementary
Methods sections 6, 13 and Supplementary Notes section 6). The only
significant correlation between a host property and a taxonomic
group is a negative one between age and the abundance of an
unknown Clostridiales genus (P, 0.02) containing three obligate
anaerobes (Supplementary Fig. 12a; see Supplementary Notes section
6.2). It should be noted that age is not constant across the nationalities
(in our data set, Italians are relatively old and Japanese young), but
that individuals did not stratify by nationality, indicating that this is
not a confounding factor. Our data did not reveal any correlation
between BMI and the Firmicutes/Bacteroidetes ratio and we thus
cannot contribute to the ongoing debate on the relationship between
this ratio and obesity29,30.
In contrast to the minor phylogenetic signal, we found several
significant functional correlations with each of the host properties
studied (after correcting for multiple testing to avoid artefacts; see
Supplementary Methods section 13), indicating that metagenomics-
derived functional biomarkersmight bemore robust than phylogenetic
ones. For example, the abundance of ten orthologous groups varies
more between than within nationalities (Supplementary Table 14),
although overall, the functional composition in total was remarkably
similar among the nations (also with respect to the functional core; see
Supplementary Fig. 13). For gender, we find five functional modules
and one orthologous group that significantly correlate (P, 0.05; for
example, enriched aspartate biosynthesis modules in males; see Sup-
plementary Table 16). In addition, twelve orthologous groups signifi-
cantly correlate with age (Supplementary Table 17). For instance,
starch degradation enzymes such as glycosidases and glucan phos-
phorylases increase with age (which could be a reaction to decreased
efficiency of host breakdown of dietary carbohydrates with age31) and
so does the secA preprotein translocase (Supplementary Fig. 14).
Conversely, an orthologous group coding for the facultative s24 sub-
unit of RNA polymerase, which drives expression under various stress
responses and is linked to intestinal survival32, decreases with age
(Fig. 4a). One explanation for this could be the reduced need for stress
response in the gut due to the age-associated decline in host immune
response33 (immunosenescence). Our analyses also identified three
marker modules that correlate strongly with the hosts’ BMI (Sup-
plementary Table 19 and Supplementary Fig. 14), two of which
are ATPase complexes, supporting the link found between the gut
microbiota’s capacity for energy harvest and obesity in the host34.
Interestingly, functional markers found by a data-driven approach
(derived from the metagenomes without previous knowledge) gave
much stronger correlations than genes for which a link would be
expected (for example, susC/susD, involved in starch utilization26;
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Figure 4 | Correlations with host properties. a, Pairwise correlation of RNA
polymerase facultative s24 subunit (COG1595) with age (P5 0.03,
rho520.59). b, Pairwise correlation of SusD, a family of proteins that bind
glycan molecules before they are transported into the cell, and BMI (P5 0.27,
rho520.29, weak correlation). c, Multiple orthologous groups (OGs)
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Supplementary Methods section 13 and ref. 40 for details; P5 2.753 1025,
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biosynthesis (M00051), significantly correlatingwith BMIwhen combined into
a linear model (P5 6.7863 1026, adjusted R25 0.82).
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Fig. 4b). Linear models combining the abundance of only a few func-
tional modules correlate even better with host properties (Fig. 4c, d). It
should be noted that given the possibility of many confounding
variables owing to the heterogeneity and size of our cohort, these
observations will need to be substantiated using larger, independent
cohorts in the future. Furthermore, patterns in metagenomics data
can (partly) reflect indirect factors9 such as genome size35 (the smaller
the average genome size of a sample, the higher the relative fraction
of single copy genes therein), which, however, does not matter for
diagnostics.
Although individual host properties do not explain the entero-
types, the latter might be driven by a complex mixture of functional
properties, by host immune modulation or by hitherto unexplored
physiological conditions such as transit time or pH of luminal contents.
Furthermore, the threemajor enterotypes could be triggered by the three
distinct pathways for hydrogendisposal36 (SupplementaryNotes section
6.4). Indeed, despite their lowabundance,Methanobrevibacter (ametha-
nogen) and Desulfovibrio (a known sulphate-reducer) are enriched in
enterotypes 3 and 1, respectively.
Taken together, we have demonstrated the existence of enterotypes
in the human gut microbiome and have identified three of them that
vary in species and functional composition using data that spans
several nations and continents. As our current data donot revealwhich
environmental or even genetic factors are causing the clustering, and as
faecal samples are not representative of the entire intestine, we antici-
pate that the enterotypes introduced here will be refined with deeper
and broader analysis of individuals’microbiomes. Presumably, entero-
types are not limited to humans but also occur in animals. Their future
investigation might well reveal novel facets of human and animal
symbiotic biology and lead to thediscovery of thosemicrobial properties
correlatedwith the health status of individuals.We anticipate that they
might allow classification of human groups that respond differently to
diet or drug intake. Enterotypes appear complex, are probably not
driven by nutritional habits and cannot simply be explained by host
properties such as age or BMI, although there are functional markers
such as genes or modules that correlate remarkably well with indi-
vidual features. The latter might be utilizable for diagnostic and per-
haps even prognostic tools for numerous human disorders, for
instance colorectal cancer and obesity-linked co-morbidities such as
metabolic syndrome, diabetes and cardiovascular pathologies.
METHODS SUMMARY
Sample collection.Humanfaecal samples fromEuropean individualswerecollected
and frozen immediately, andDNAwaspurified as describedpreviously37. Sequencing
was carried out by Sanger-sequencing random shotgun DNA libraries of 3 kb using
standardprotocols establishedatGenoscope.For sequenceprocessing, cloningvector,
sequencing primers and low-quality bases were end-trimmed from rawSanger reads,
and possible human DNA sequences were removed. Reads were processed by the
SMASH comparative metagenomics pipeline38 for assembly and gene prediction.
Informed consent was obtained from the 22 European subjects. Sample collec-
tion and experimentswere approved by the following ethics committees:MetaHIT
(Danish), ethical committee of the Capital Region of Denmark; MetaHIT
(Spanish), CEIC, Hospital Vall d’Hebron; MicroObes, Ethical Committee for
Studies with Human Subjects of Cochin Hospital in Paris, France; MicroAge,
Joint Ethical Committee of the University of Camerino.
Phylogenetic annotation. Phylogenetic annotation of samples was performed by
(1) aligning reads (Sanger/Illumina) against a database of 1,511 reference genomes
(listed in Supplementary Table 3); or (2) classifying 16S rDNA reads using RDP
classifier39. Genus and phylum abundance was estimated after normalizing for
genome size for the former, and for 16S gene copy number for the latter.
Functional annotation.Geneswere functionally annotated usingBLASTPagainst
eggNOG (v2) and KEGG (v50) databases. Protein abundances were estimated after
normalizing for protein length. Functional abundance profiles at eggNOG, KEGG
orthologous group, functional module and pathway level were created.
Clustering and classification. Samples were clustered using Jensen–Shannon dis-
tance andpartitioningaroundmedoid (PAM)clustering.Optimalnumberof clusters
was estimated using the Calinski–Harabasz (CH) index. We used the silhouette
validation technique for assessing the robustness of clusters. Additionally, within a
cross-validation scheme, we trained predictive decision tree models on clusters
obtained using the same clustering method and evaluated the classification of
hold-out samples by accuracy, average precision and average precision gain.
Statistics. Correlations betweenmetadata and feature abundanceswere computed as
describedpreviously40,basedonmultiple-testingcorrectedpairwiseSpearmancorrela-
tion analysis and stepwise regression formulti-featuremodel building. For categorical
metadata and enterotype comparisons, samples were pooled into bins (male/female,
obese/lean, one enterotype/rest, specific nationality/rest etc) and significant features
were identified using Fisher’s exact test withmultiple testing correction of P values.
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3.3 Article 3: “Ecological resilience of the human
gut microbiome and human healthy”
Many recent studies have attempted to determine the mechanism through which the
human gut microbiome affects human health. The goal was to identify so-called
‘bad’ bacteria that could cause disease or influence human health. Unfortunately,
the search for such bacteria was unfulfilled, as each human gut microbiome harbours
distinct bacterial strains. The idea that human gut microbiome composition would
be defined by expected factors — e.g. disease, lifestyle, and age — also lost strength
after the discovery of enterotypes described in article two. However, during 2011, sev-
eral articles related to IBD and model organisms demonstrated that some commensal
bacteria can regulate the innate immune system. Moreover, subproducts of the gut
microbiome (e.g. SCFAs) are known to be important for intestinal cell function and
the control of inflammatory responses. This knowledge changed the scientific per-
spective on the human gut microbiome and indicated that defining the constituents
of a healthy microbiome is key to understanding what constitutes an unhealthy mi-
crobiome. Although homeostasis was defined in 1929 by Walter Bradford Cannon,
it had not been explored by many microbiome studies. Homeostasis is the property
of a system that regulates its internal environment and tends to maintain a stable,
constant condition of properties [120]. Because many articles had failed to identify
‘bad’ bacteria, the theory of homeostasis gained force to explain the dynamics of
unhealthy gut microbiomes. A microbial imbalance in humans is defined as dysbiosis
and is characterised by the overgrowth of a few species, which can damage smaller,
beneficial species. Dysbiosis had been explored in several articles as a possible ex-
planation for the dynamics of an unhealthy human gut microbiome. Thus, a healthy
microbiome is defined as a high-diversity environment (many bacterial species with
low abundance and even distribution), whereas an unhealthy microbiome is a low-
diversity environment (overgrowth of a few species and uneven distribution). After
exploring the MetaHIT data, I believe that dysbiosis may play a prominent role in
shaping the human gut microbiome. Although the cause of dysbiosis in the gut is cur-
rently unknown, its effects on the gut microbiome can be observed. Since publishing
the human microbiome gene catalogue, we have been interested in how microorgan-
isms interact with each other. Because few organisms found in nature exist alone,
especially bacteria, describing a bacterial community in full is a critical component
of understanding the role of each species in the community and its relationship with
the host. Therefore, the human gut microbiome species network published in the
first article was the initial step in elucidating the microbiome ecology of the human
gut. Many studies have been unable to find biomarkers to explain the relationship
among microbiome variation and expected factors such as diet, health status, age,
lifestyle, and nationality. However, many others have reported that differences in di-
versity could explain health status, supporting the idea that ecology theory could be
applied to the human gut microbiome to find the link between gut microbiome and
disease. This third article presents a biological explanation for human gut microbiome
variation. Furthermore, it defines both healthy and unhealthy gut microbiomes. In
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contrast to general beliefs, the unhealthy microbiome is not composed of ‘bad’ bacte-
ria but rather is composed of fragments of a healthy microbiome with an overgrowth
of Bacteroides, Prevotella, and Escherichia species, suggesting an imbalance in the
ecosystem. These characteristics match those that define dysbiosis. The loss of some
species and the growth of others likely stimulates immune response and aggravates
inflammation (Figure 3.3).
This article was the first to apply theories of microbial ecology to explain the rela-
tionship between variation in composition of the human gut microbiome and disease.
It was also the first to use four datasets generated using three technologies — metage-
nomic sequencing with Illumina, metagenomic microarray, and 16S rRNA sequencing
— demonstrating that the results were not biased by methodology. Moreover, sam-
ple preparation was carried out by other groups using various extraction methods.
The analyses are also true for different levels of taxonomy annotation, including
16S rRNA operational taxonomic unit 100%, strain, species, and genus. All three
datasets contain more than 100 samples, which provide adequate result robustness.
Since my group defined its first species network, I have been interested applying
microbial ecology theory to explain the microbiota–disease link and integrating it
with published results. The challenge was to combine ecology theories with known
gut parameters and report results in the contexts of enterotypes, diversity, immune-
system, B/F ratio, and diet, creating one model which can explain not only the results
observed in the third article but also results from other studies. The article provides
answers for three main questions related to the human gut microbiome. First, can any
biomarker identify an unhealthy human gut microbiome? This question is important
because its answer can be used to create medical tools for rapid profiling of the gut
microbiome and determination of whether intervention is necessary. Such tools might
also be used in the prevention of IBD relapse. Second, is the human gut microbiome
composed of one or many ecosystems? The second article suggests the existence of
three completely independent gut microbiomes. Answering this question may help
to develop medical treatments tailored to various gut microbiome types. Finally, one
of the most relevant questions about the gut microbiome is whether the shift in gut
microbiome composition a cause or consequence of disease? Many articles thus far
have been unable to answer this question. In addition to answering these questions,
we generated a model capable of integrating many of the results published thus far,
putting together small pieces of this puzzle to form a big picture.
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Figure 3.3: Figure from review article [109] as figure 4. Dysbiosis model explains
how an healthy gut environment become unhealthy. Instead of ‘bad’ bacteria the
model suggests lack of ‘Peace-keeping’ bacteria by altered gut environment may be
the cause of gut diseases. The model also suggests that inflammation can favour the
selection of pathogenic bacteria [109].
Ecological resilience of the
human gut microbiome and
human healthy
Marcelo Bertalan, MetaHIT Consortium.
E
xplanations of the association between the human gut micro-
biome and disease from an ecological viewpoint are gaining
increasing acceptance, as many studies have reported that un-
healthy samples have a species diversity that is lower than that in
healthy samples. However, the impact of low diversity in the gut mi-
crobiome ecosystem is still unknown. By analysing four independent
datasets from the human gut microbiome, we observed that the B/F
ratio is a strong indicator of microbial gut composition. This ratio
is negatively correlated with diversity and can explain much of the
variance in our datasets. High-diversity samples comprise almost all
species found in the gut microbiome, whereas low-diversity samples
are subsets of high-diversity samples (i.e. nested). Using a species
network, we show that species with a high number of species degrees
(number of links among species) are the first to disappear when di-
versity decreases owing to a perturbation in the ecosystem. Further-
more, intra-sample variance is negatively associated with diversity.
Our results resemble dysbiosis, with overgrowth of Bacteroidetes
species and a decrease in Firmicutes and Actinobacteria. Species
networks and functional analysis indicate that the microbiome shift
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is related to the fitness of species under inflammatory stress. There-
fore, an unhealthy microbiome is defined by the absence of specialist
species and an increase in generalist species, which can thrive under
a wide variety of environmental conditions. Here, we propose the
first model capable of explaining human gut microbiome variance
and its relationship to disease.
1 Introduction
The gut microbial flora contributes to the health of the human body. It
performs several useful functions, including fermenting otherwise indigestible
carbohydrates to SCFAs, forming the immune system in early childhood,
preventing the growth of pathogenic bacteria, regulating the development of
the gut lining, and producing vitamins for the host. The gut microbiome
influences the amount of energy an individual can obtain via diet [1], and
the microbial modification of bile acids affects lipid metabolism in the host
[2]. The gut microbiota also plays a role in both innate [3] and adaptive
[4] immune responses. In the gut of germ-free mice, epithelial cells renew
at a slower rate than those in their bacterially colonised counterparts [5].
Studies have demonstrated the impact of the human gut microbiota on its host.
Therefore, characterisation of variations in the human gut microbiome and the
identification of key microbial species are important steps in defining healthy
and unhealthy gut microbiomes.
In general, the composition of the human gut microbiome is dominated by
two phyla, Bacteroidetes and Firmicutes, which display distinct phenotypes.
Whereas most Firmicutes species in the gut microbiome are Gram-positive,
strictly anaerobic, and endospore forming, Bacteroidetes species are Gram-
negative and aerotolerant and do not form endospores. Firmicutes is a diverse
taxonomic group in the gut microbiome, with many families present as commen-
sal bacteria, whereas Bacteroidetes is dominated by two genera, Bacteroides
and Prevotella [6]. Members of Bacteroidetes also produce high levels of acetate
and propionate, whereas Firmicutes species produce high amounts of butyrate
[7].
Complex interactions among multiple factors such as diet, genotype, physi-
ology, environment, and the immune system have been proposed to play an
important role in shaping gut microbiome composition [8]; however, the exact
mechanisms of their effects remain unknown, and modelling approaches have
proven unsuccessful in uncovering them. Despite extensive studies, the link
between the microbiome and disease remains unclear, and no single species
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has been identified to explain IBD or obesity. However, some observations
have been consistently reported. For example, the microbiome of IBD patients
is lower in species richness (the number of unique species in a sample) than
that of healthy individuals, and dramatic reductions in the relative abundance
of members of Firmicutes have been observed in IBD patients [9, 10, 11, 12].
Members of Firmicutes are known producers of acetate and butyrate, which
are important SCFA metabolites with potent anti-inflammatory properties;
thus, members of this group have garnered considerable interest [13, 14, 15].
Clostridial clusters IV and XIVa exhibit lower relative abundance in patients
with IBD than they do in healthy controls, suggesting that this cluster may
have an important anti-inflammatory role in the gut microbiome [16]. Analysis
of the intestinal tissue from IBD patients has revealed that Prevotella species
was 3.6 times more abundant at an inflamed site than at a non-inflamed site,
accounting for 25% of the total community present in inflamed tissue [10]. In
addition, high abundance of members of the genera Bacteroides and Prevotella
has been observed in mucosal biopsy specimens from ulcerative colitis patients
[17].
Dysbiosis, or disequilibrium of the microbiota, may explain the association of
the microbiome with inflammatory disease. Because the gastrointestinal tract
forms the largest interface between the immune system and the environment,
it may have an effect on the microbiome. The normal mucosa of the small and
large intestine experiences continuous low-grade (physiologic) inflammation that
is absent from the gut of adult germ-free mice and the intestines of newborn
humans [18, 19, 20], suggesting that the presence of microorganisms in the
gut is enough to create low-grade inflammation. Regulatory T cells (Tregs),
which express the Foxp3 transcription factor, play a critical role in immune
homeostasis [21] and in the distinction of self and non-self cells [22]. Bacterial
species — particularly Gram-positive, spore-forming species — are prominent
players in the induction of colonic Tregs. Specifically, Clostridium species
belonging to clusters IV and XIVa are potent inducers of Tregs in the colon
[23]. Thus, microbial flora is crucial to intestinal homeostasis.
In the present study, we analysed four human gut metagenomic datasets
obtained using three technologies (microarray, sequencing, and 16S rRNA). We
observed a strong pattern resembling dysbiosis within all four datasets. By
combining our results with those of previous studies, we proposed definitions
of healthy and unhealthy ecological states of the gut microbiome. A healthy
community is characterised by high diversity, low B/F ratio, high number
of species degrees, and consistent microbiota composition. An unhealthy
microbiome is defined as a subset of the healthy microbiome with disrupted
species networks caused by a disturbance in the ecosystem. Because such
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disturbances affects the gut microbiome in the various ways, unhealthy samples
display inconsistent composition and great variation, which may explain the
difficulty in identifying biomarker species with strong associations to disease
states.
2 Results
2.1 Diversity and species composition.
Defining human gut microbiome composition is an important step in under-
standing its relationship with disease. Bacteroidetes and Firmicutes phyla are
reportedly the most abundant in the human gut microbiome, and we confirmed
this observation in all four datasets (Sup. Figure 1). These two phyla repre-
sented more than 90% of the species abundance in all samples. Moreover, these
phyla displayed the highest variance across all samples, although variance in
Bacteroidetes was high than that in Firmicutes (Sup. Figure 2). To visualise
the change in relative abundance from Firmicutes to Bacteroidetes, we plotted
species abundance coloured by phyla and sorted by Bacteroidetes abundance
(Sup. Figure 3). The results revealed a pattern in which species abundance is
lower in samples with high B/F ratio and higher in those with low B/F ratio.
The Shannon’s diversity index was used to confirm this observation. In all
datasets, diversity was negatively associated with Bacteroidetes abundance and
positively associated with Firmicutes abundance (Figure 1). Thus, samples
with a high abundance of Bacteroidetes species have lower diversity, whereas
those with a high abundance of Firmicutes display high diversity.
2.2 One or multiple ecosystems
The diversity of a sample is strongly associated with the shift in species
composition (Bacteroidetes and Firmicutes). However, whether low-diversity
samples are a completely new ecosystem or a subset of a high-diversity system
is unclear. To study this question, we used beta diversity (a measure of the
number of different species between two samples) and delta diversity (a measure
of the number of common species between two samples). We observed that
delta diversity was higher than beta diversity for these ecosystems, which
indicates that a greater proportion of the differences between these two groups
is determined by the variation in abundance and not by new species. This
finding supports the idea that low-diversity samples are subsets (or nested) of
a high-diversity ecosystem (Figure 2) and not a new ecosystem, although they
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Figure 1: Association among diversity and Bacteroidetes/Firmicutes (BF) ratio for
each sample. The x-axis shows the log of relative abundance of B/F. The y-axis
shows the Shannon’s diversity index. Samples were classified into enterotype by the
most abundant group in each sample represented by different colours and shapes.
The size of the sample represents its richness. The linear model in blue describes
the association among diversity with R2. (A) 16S rRNA dataset with 190 samples
[24]. (B) 16S rRNA dataset with 297 samples [25]. (C) MetaHIT microarray with
121 samples. (D) MetaHIT sequencing with 124 samples [9]
.
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may contain few ‘new’ species — species that are not present in high-diversity
samples. However, those are present in low abundance.
2.3 Diversity and Enterotypes
Species abundance (Sup. Figure 3) indicates a continuous distribution of
Bacteroidetes abundance, not a discrete distribution as has been suggested [6].
Moreover, our results indicated that the human gut microbiome is composed
of just one ecosystem, which means that most of the difference observed is
determined by the loss of species and variation in relative abundance. A
previous study has established that individuals can have three enterotypes
of gut microbiome [6], and we used the enterotype algorithm to cluster four
independent datasets. The overall result revealed that each enterotype has a
different median value according to the Shannon’s diversity index, confirming
our previous observation that the high relative abundance of Bacteroidetes
is associated with low diversity. The Firmicutes enterotype had the highest
diversity followed by the Prevotella and Bacteroides enterotypes. Therefore,
diversity can also explain the enterotype clusters (Figure 3). Combining these
results (Shannon’s diversity index, delta diversity, continuous distribution and
enterotype cluster) with results from published studies demonstrating the shift
of the clusters (from Firmicutes to Bacteroidetes), we propose that the three
enterotypes are one ecosystem, and the clusters are states and therefore should
be labelled as ‘Enterostages’.
2.4 Diversity and species degree
Species degree can be important in explaining diversity effects on ecosystems.
Therefore, using the species network, we investigated the species degree for all
datasets. We found that organisms have a higher number of species degrees
with species from the same phyla. Bacteroidetes species have the lowest number
of degrees, whereas Firmicutes has the highest number of degrees with itself
and other phyla (Sup. Figure 4). The number of degrees in a species can be
interpreted as an indicator of how dependent bacteria are on other organisms
in the ecosystem. Therefore, if the community is unbalanced with decreasing
diversity, it is likely that species with high degrees (more dependent) will
disappear first, as the loss of one species in the highly connected part of the
network affects all associated species.
To test this theory, we first correlated species abundance with diversity to
determine which species increased in abundance when diversity decreased and
vice versa. Many of the species that were positively correlated with diversity
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Figure 2: Beta and delta diversity. Beta diversity is the number of different species
between two groups. Delta diversity as the number of similar species between two
groups. Samples were ordered using the Shannon’s diversity index and grouped with
a window size of 20 samples and a sliding window of 1. Beta and delta diversity were
calculated against the reference group (the 20 samples with the highest diversity)
and moved in the direction of low diversity. Delta diversity in red represents the
percentage of similar species, and beta diversity in blue represents the percentage
of different species. (A) 16S rRNA dataset with 190 samples [24]. (B) 16S rRNA
dataset with 297 samples [25]. (C) MetaHIT microarray with 121 samples. (D)
MetaHIT sequencing with 124 samples [9].
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Figure 3: Shannon’s diversity index for each sample classified in enterotype clusters.
In all four datasets, the Firmicutes enterotype had the highest median diversity
index. Although the Prevotella cluster had some of the highest evenness, it had
medium richness. Overall, Prevotella had the second lowest diversity index. The
Bacteroides cluster had the lowest diversity index in all datasets. These data are
important because a healthy microbiota reportedly has diversity higher than that in
an unhealthy microbiota. Therefore, unhealthy individuals are more likely to display
the Prevotella or Bacteroides cluster. (A) 16S rRNA dataset with 190 samples [24].
(B) 16S rRNA dataset with 297 samples [25]. (C) MetaHIT microarray with 121
samples. (D) MetaHIT sequencing with 124 samples [9].
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Figure 4: Number of species degrees in the species network over diversity. The
number of species degrees increased with diversity. (A) 16S rRNA dataset with 190
samples [24]. (B) 16S rRNA dataset with 297 samples [25]. (C) MetaHIT microarray
with 121 samples. (D) MetaHIT sequencing with 124 samples [9].
belonged to Firmicutes (Sup. Figure 5), whereas most of the species that
were negatively correlated with diversity belonged to Bacteroidetes. Therefore,
species analysis also confirmed previously observed associations between diver-
sity and phyla. Subsequently, we correlated this measurement with the number
of species degrees. The results suggested that species with a high number of
degrees are the first to disappear from an ecosystem when diversity decreases
(Sup. Figure 6). The number of species degrees increased with diversity in all
datasets (Figure 4). Therefore, species are less dependent in the setting of low
diversity and more dependent in high diversity.
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2.5 Interindividual variance and ecosystem stability
Although diversity may explain most of the variance in human gut microbiome
data, the impact of diversity on the ecosystem is unknown. Therefore, to
observe the impact of evenness, we selected the top 100 species from each
enterotype cluster to observe which species were more abundant and how
bacterial abundance changes with diversity. The cluster with the highest
diversity displayed a low B/F ratio, a high number of species, low species
variation, low abundance, and an even distribution. The cluster with the next
highest diversity showed an increased B/F ratio and a higher variance across
samples. The cluster with the third highest diversity had the most extreme
profile, displaying very high abundance of a few species as well as species with
the highest variance across samples and the highest B/F ratio. Therefore,
samples with high diversity had lowered variance and were more similar to each
other in terms of species composition than were samples with low diversity
(Figure 5). This result is important, as it may explain the lack of species
markers associated with disease because low-diversity samples have the highest
variance, and therefore, do not display similar species prevalence. Furthermore,
the effect of diversity also changed the rankings of the most abundant species
in the three diversity groups. In cluster 1, the top Firmicutes species are
mostly Clostridium species. Clostridium has been reported to regulate immune
homeostasis, and a high number of species have been shown necessary for
efficient Treg induction [23]. Therefore, high-diversity ecosystems have lower
interindividual variance and thus seem more stable.
2.6 Adaptation: Generalist and specialist species
The fact that low-diversity samples are a subset of high-diversity samples
suggests that low-diversity samples would not be able to fulfil the requirements
for normal gut function. To test this hypothesis, we compared the functional
capacity of high- and low-diversity samples. We observed that low-diversity
samples are rich in endotoxins (Sup. Figure 8). This characteristic supports
the taxonomic analysis, as most of the high-abundance species in low-diversity
samples belong to Bacteroidetes (Gram-negative). Moreover, low-diversity
samples are rich in catalase and peroxidase genes. Peroxidase genes are overrep-
resented in aerotolerant species such as Bacteroides, and catalase was observed
in facultative anaerobic species such as E. coli. The capacity of those species
to survive in the presence of oxygen has been previously reported [26, 27], and
the enrichment of those genes in low-diversity samples suggests the presence of
oxygen in the ecosystem, which could be caused by the inflammatory response
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Figure 5: Variance of species abundance over diversity. Samples were ordered
by diversity with a window of 20 samples and a slide window of 1. The sum of
variance of all species in each group was measured and compared with the mean
Shannon diversity index for the same group. The figure shows a strong negative
correlation among species abundance variance and diversity. Species in low-diversity
samples have high variance in abundance, and those in high-diversity samples have
low variance in abundance. (A) 16S rRNA dataset with 190 samples [24]. (B) 16S
rRNA dataset with 297 samples [25]. (C) MetaHIT microarray with 121 samples.
(D) MetaHIT sequencing with 124 samples [9].
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of ROS. The presence of oxygen gives aerotolerant/facultative anaerobes an
advantage by increasing their fitness, thereby increasing their abundance in the
environment. A high abundance of Enterobacteriaceae has been reported in
IBD patients [28, 29, 30]. Furthermore, genes responsible for the production
of the anti-inflammatory compounds butyrate and acetate are enriched in
high-diversity samples, confirming the taxonomic distribution as Firmicutes
in these samples. Butyrate decreases pro-inflammatory cytokine expression
via inhibition of nuclear factor kappa B [15], suggesting that high-diversity
microbiomes have a greater capacity to reduce inflammatory response.
Spore genes are also enriched in high-diversity samples. Clostridium is the
genus with the highest number of spore-related genes in the gut microbiome,
confirming the known capacity of this group to produce spores. Analysis of
carbohydrate enzymes revealed that 50% of all genes are found in only three
genera: Bacteroides, Lactobacillus, and Clostridium. The distribution of car-
bohydrate enzymes is not equal for all genera. Bacteroides has 80 families,
Lactobacillus 40, and Clostridium 51, although Lactobacillus has two times
more carbohydrate enzymes than Clostridium. Comparing Bacteroides and
Lactobacillus, we observed that glycoside hydrolase (GH) GH13, GH1, GH73,
and GH25 are enriched for Lactobacillus, and GH2, GH3, and GH43 are en-
riched for Bacteroides, suggesting different roles for these genera in the gut.
Carbohydrate enzyme capacity separated the genera into three clusters, indi-
cating three major functional groups of carbohydrate enzymes (Sup. Figure 9).
The fact that Bacteroides species can increase abundance when the ecosystem
is under stress suggests a greater capacity to adapt to changes than that of
other species in the gut microbiome.
Bacterial genome size has been associated with adaptation, as free-living
bacteria have genomes that are larger than those of host-restricted bacteria [31,
32]. To confirm this association, we analysed the bacterial genome size for the
most abundant genera found in the gut microbiome. We found that Bacteroides
and Escherichia genera have large genomes, supporting the idea that they are
more capable of adapting to environmental changes (Sup. Figure 7). Both of
these genera have been shown to be overrepresented in gut microbiome samples
from IBD patients. Although these genera belong to different phyla, both are
Gram-negative, aerotolerant, and facultative. To test this idea further, we
analysed the distribution of average genome size within a sample from the
MetaHIT dataset. The results showed that average genome size decreases
with increasing sample richness. The overall functional analysis indicated the
capacity of each genus to adapt to changes in the environment. Some species
are specialists, being present only under optimal conditions and producing
spores when the ecosystem changes, whereas others were like generalists with
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diverse (large) genomes capable of adapting to changes in the environment.
Some Bacteroides species have the highest number of carbohydrate enzymes
of all species found in the human gut representing the highest number of
carbohydrate enzyme families.
3 Discussion
The shift observed in our results is similar to that exemplified by dysbiosis, with
overgrowth of Bacteroides, Prevotella and E. coli. These species are known
for their capacity to survive under oxidative stress. Interestingly, the same
shift in species has been observed in IBD [10], obese [33], and knockout mice
(e.g. Nlrp6 -/-, Nlrp3 -/-, Rag-/-, and T5KO) [34, 35, 36, 37], demonstrating
that the immune system plays a central role in shaping the composition of the
microbiota [38]. The observed shift affects the production of SCFAs, especially
butyrate, which may in turn influence colonic epithelial cells because butyrate
is used as a primary energy source [39]. Moreover, G-protein-coupled receptor
43-SCFA interactions affect inflammatory responses, establishing a link among
diet, gastrointestinal microbiome, and immune and inflammatory responses
[40].
Phenotypic characteristics are properties of their common ancestors, and
ecological interactions have been shown to be phylogenetically conserved across
the tree of life, with closely related species interacting with similar partners [41].
We confirmed this assumption in the four datasets we analysed, in which most of
the species interacted with other species from the same phyla in the ecological
network. In ecological communities, species can have negative or positive
interactions with one another (e.g. competition/predation and mutualism).
Our ecological network revealed that most of the interactions among species
are positive, suggesting mutualism. Recently, mutualistic ecological networks
have been found to have minimal competition and increased alpha diversity
[42, 43]. We observed increased richness in samples with high relative abundance
of Firmicutes and a high number of species degrees. It has been said that
“nestedness in mutualistic ecological networks is the tendency for ecological
specialists to interact with a subset of species that also interact with more
generalist species” [44]. Firmicutes species display a high number of interactions
with species from different phyla in the network we developed, suggesting that
in the gut microbiome, some Firmicutes species function as intermediaries
among specialists and generalists. Nestedness reduces effective interspecific
competition and enhances the number of coexisting species [42], and nested
networks naturally emerge if new species are more likely to enter a community
page 13 of 33
in which they will have a minimal competitive load [42]. A highly connected
and nested architecture promotes community stability in mutualistic networks
[43]. Intra-species variation supports the stability of a community with high-
diversity samples. Therefore, we suggest that high Firmicutes samples may
begin as a nested mutualism ecological network but, with an increased number
of species, becomes nested and stable. Of interest is the fact that most of
the unknown species are mainly found in high-diversity samples. Taxonomic
prediction methods suggest that most of those species belong to the Firmicutes
phylum.
To explain the variation in the human gut microbiome and inflammatory
responses, we propose the following model (Figure 6). Healthy individuals
have a high-diversity microbiome [10, 11, 6, 45], and our results associate high
diversity with a high abundance of Firmicutes. Disturbances in the balance (e.g.
viruses, pathogens, antibiotics, diet, allergy, and ageing) can lead to dysbiosis
and reduce diversity. The first species to disappear have high species degrees
and small genome size. Firmicutes — more specifically, Clostridium species
— predominate in this group. This disappearance abrogates the inflammatory
response that is mediated by these organisms [23]. To survive oxidative stress,
Clostridium species produce endospores, whereas species with higher tolerances
to inflammatory stress continue to grow, decreasing the production of SCFAs
and increasing LPS levels, as most of the species capable of surviving ROS in
the gut are Gram-negative.
For example, the role of Bifidobacteria may be related to the spacing of tight
junctions of the cells lining the gut [46]. A decrease in the abundance of Bifi-
dobacteria would increase the space between the cells, increasing permeability.
In case of high abundance and concentration of Gram-negative bacteria, the
loss of Bifidobacteria species in turn enhances the amount of LPS passing out of
the gut wall. This change causes endotoxaemia and inflammation, which may
induce a number of metabolic disorders [46]. A high abundance of Actinobac-
teria is found in high-diversity samples, and Bifidobacteria is one of the first
to disappear from the network when diversity decreases. The increase in LPS
worsens the inflammatory response, especially that of E. coli, because the LPS
of Bacteroides is 10 to 1,000 times less toxic than that of E. coli [47]. When the
relative abundance of Bacteroidetes and Escherichia species increase, bacterial
density also increases [37]. If the immune system is capable of controlling the
overgrowth of these bacteria and decreasing bacterial concentration, the inflam-
mation will be reduced. If not, the individual will be diagnosed with severe
inflammation and treated with antibiotics and anti-inflammatory drugs [48],
thereby reducing these bacterial concentrations. With no inflammatory signals,
Clostridium species will grow again, inducing Tregs and restoring homeostasis.
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Figure 6: Model combining the results from this article and published results. The
model explains the dynamics of the human gut microbiome from high diversity to low
diversity. It also offers an explanation for the mechanism underlying the restoration
of the microbiome composition, as reported in antibiotic experiments and studies in
mice. The transition from Gram-positive to Gram-negative has been also previously
reported. Our results placed the enterotypes into three ecological stages, which can
be related to diseases.
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This model predicts how environmental changes will impact the microbial
ecosystem and how overgrowth of certain groups can reinforce these changes,
creating a positive feedback loop. The model also aids understanding of
dysbiosis and offers an explanation for its transmissibility [34], because low-
diversity samples have a high abundance of LPS, active inflammatory response,
and high bacterial concentration, which is likely to induce inflammation in the
new host. The opposite is untrue, however, as specialist species only colonise
the ecosystem under optimal conditions. Our model helps to explain whether
the shift in the human gut microbiome is a cause or a consequence of disease,
and the results suggest that is both. The microbiome shifts as consequence
of inflammatory response, but the species capable of survival in the stressed
environment may worsen inflammation via LPS, increased gut permeability,
and reduced capacity to regulate the immune-system, giving the human gut
microbiome a causative role in disease.
Moreover, our model helps to explain observations of obesity in mice. Obese
mice reportedly have a high abundance of Firmicutes, and mice on a high-
carbohydrate diet display an increase in the relative abundance of Bacteroidetes.
Our results suggest that Firmicutes are the specialists and therefore will grow
in the ecosystem that accompanies a high-carbohydrate diet. Therefore, mice
on low-carbohydrate diets display a decrease in Firmicutes abundance, which
increases the relative abundance of Bacteroidetes. Together, these data allow
us to propose an ecological model that describes the community changes
that go along with richness decrease and hypothesises its underlying causes
(inflammation/ROS) and the effects it has on host interplay. In addition, this
theory allows the linkage of well-known gut parameters and reported results
(enterotypes, B/F ratio, richness, immune-system, and diet), bringing us one
step closer to a full understanding of the ecological underpinnings of gut health.
Methods
Taxonomy: Taxonomy for genes in the microarray and sequencing data was
carried out using nucleotide Basic Local Alignment Search Tool (BLAST),
selecting the best hit. Only alignments with more than 95% identity and
alignment length longer than 100 base pairs were accepted. The full-path
taxonomy information (strain to kingdom) was collected from the National
Center for Biotechnology Information (NCBI) taxonomy database.
Species abundance: Species abundance was calculated using the mean, count
(from sequencing), or signal (from microarray) from all genes for each species.
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The abundance was then normalised for relative abundance, with all samples
having 100%.
Phylum abundance: Phylum abundance was determined by summing the
relative abundance of all species that belonged to each phylum.
Phylum variance: Variance (σ2) for each phyla was calculated in R using
the function var.
Species distribution: Species abundance and phylum abundance were cal-
culated for each sample (see species abundance and phylum abundance), and
samples were sorted according to Bacteroidetes. Each phylum received a colour
from the RColorBrewer package using palette Set3.
Enterotype clusters: Enterotype clusters were created using JensenShannon dis-
tance to measure the distance among samples and partitioning around medoid
to generate the clusters, with three clusters as total number of clusters [6].
Diversity: Diversity was calculated using the Shannon’s diversity index from
package vegan, function: diversity and method ‘shannon’.
B/F ratio: B/F ratio was calculated by dividing the phylum abundance for
Bacteroidetes by the phylum abundance for Firmicutes.
Richness: Species richness or alpha diversity was calculated by the number of
species with abundance higher than 0.2% in relative abundance for all four
datasets.
Beta diversity: Beta diversity was calculated by counting the number of species
that were not shared by the two communities. The relative beta diversity is
calculated as beta diversity divided by the gamma diversity from the communi-
ties.
Delta diversity: Delta diversity was calculated by counting the number of
common species between two communities. The relative delta diversity was
calculated as delta diversity divided by the number of species in the community
with the lowest alpha diversity.
Gamma diversity: Gamma diversity was calculated by counting the total
number of unique species found between two communities.
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Relative delta and relative beta diversity in samples: To calculate the delta
diversity in samples, we first sorted all samples according to Shannon diversity
index values. The 20 samples (window size: 20) with the highest diversity were
used as a representation of a high-diversity community. Then we moved one
sample down and selected the next 20 samples (sliding window: 1) to represent
the community with low diversity. The two communities are compared using
delta and beta diversity calculations. The process continued until the last 20
samples were analysed.
Species network: To create the species network, we used the Spearman cor-
relation index. We only accepted the association between two species if the
correlation index was higher than an absolute value of 0.4.
Species degrees: Species degrees were calculated by the number of associ-
ations one species had with other species in a network (see species network).
Species abundance versus diversity: The association among species abun-
dance (see species abundance) and diversity (see diversity) was calculated with
the Spearman correlation test from R package using the stats function cor.test
method = Spearman. Only correlations with p values of < 0.001 were accepted.
Species degrees in samples: Samples are sorted by diversity (see diversity), and
the species degrees were calculated (see species degrees) for only species with a
relative abundance higher than 0.2%, a window size of 20, and a sliding window
of 1.
Species variance: Samples were sorted by diversity (see diversity), and the
species variance was calculated in R using the var function with a window of
20 samples and sliding window of 1. The sum of variance of all species in each
group (group of 20 samples) was calculated. The mean Shannon diversity index
was also calculated for each group.
Functional analysis: Genes were functionally annotated using protein BLAST
against the Evolutionary Genealogy of Genes: Non-supervised Orthologous
Groups (v2), Kyoto Encyclopedia of Genes and Genomes (v50) and Carbohydrate-
Active Enzymes Database databases. The best hit was used only if it had more
than 25% identity and alignment length longer than 100 amino acids.
Genome size: Genome size and taxonomy identification information was ob-
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tained from NCBI GenBank files.
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Supplementary material
Figure 1: Relative phylum abundance distribution from four datasets assembled
using three technologies. The x-axis shows the phyla Bacteroidetes, Firmicutes,
Proteobacteria, Actinobacteria, and other (a group of all other phyla). The y-axis
shows the relative abundance. (A) 16S rRNA dataset with 190 samples [24]. (B) 16S
rRNA dataset with 297 samples [25]. (C) MetaHIT microarray with 121 samples.
(D) MetaHIT sequencing with 124 samples [9].
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Figure 2: Relative phyla abundance variance in four datasets assembled using three
technologies. The x-axis shows the phyla Bacteroidetes, Firmicutes, Proteobacteria,
Actinobacteria, and other (the sum of variance from all other phyla). The y-axis
shows the variance. (A) 16S rRNA dataset with 190 samples [24]. (B) 16S rRNA
dataset with 297 samples [25]. (C) MetaHIT microarray with 121 samples. (D)
MetaHIT sequencing with 124 samples [9].
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Figure 3: Relative species abundance distribution from four datasets assembled
using three technologies. The x-axis shows the samples. The y-axis shows the relative
abundance for each species in each sample coloured by phyla (Bacteroidetes = green,
Firmicutes = yellow, Proteobacteria = purple, Actinobacteria = red, and other =
blue). (A) 16S rRNA dataset with 190 samples [24]. (B) 16S rRNA dataset with 297
samples [25]. (C) MetaHIT microarray with 121 samples. (D) MetaHIT sequencing
with 124 samples [9].
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Figure 4: Using the species network, we measured the number of species degrees
(link between two species) for each phyla. In all four datasets, Firmicutes displayed
the highest number of species degrees within Firmicutes and with other phyla. The
remaining phyla have greater degrees among themselves than with other phyla.(A)
16S rRNA dataset with 190 samples [24]. (B) 16S rRNA dataset with 297 samples
[25]. (C) MetaHIT microarray with 121 samples. (D) MetaHIT sequencing with 124
samples [9].
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Figure 5: Species abundance versus diversity. We identified which species increase
and decrease in relative abundance when diversity increases. In all four datasets,
more species increased in abundance when diversity increased. Most of the species
with increased abundance belonged to Firmicutes and Actinobacteria. The species
decreasing in abundance were mostly from Bacteroidetes. (A) 16S rRNA dataset
with 190 samples [24]. (B) 16S rRNA dataset with 297 samples [25]. (C) MetaHIT
microarray with 121 samples. (D) MetaHIT sequencing with 124 samples [9].
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Figure 6: To understand how diversity affects the species network, we correlated
species degree with diversity. The y-axis shows the number of species degrees
measured for each species. The x-axis shows the correlation of species abundance
versus diversity divided into three groups. Group 1: Species significantly negatively
correlated with diversity. Group 2: Species with no significant correlation with
diversity. Group 3: Species significantly positively correlated with diversity. Each
circle represent a species, coloured by phylum. The size of the circle represent the
mean abundance over all samples. (A) 16S rRNA dataset with 190 samples [24]. (B)
16S rRNA dataset with 297 samples [25]. (C) MetaHIT microarray with 121 samples.
(D) MetaHIT sequencing with 124 samples [9].
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Figure 7: We used taxonomic identification to find the genome size of each taxonomic
organism in the dataset. The genome size is grouped by genus to provide an estimation
of overall size for each genera, as individual species can vary in size. Bacteroides and
Escherichia have the highest median genome size in the most abundant genera in
the human gut microbiome.
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Figure 8: Functional annotation of the most abundant families in the human
gut microbiome. For each taxonomic group, the number of annotated genes was
counted. The functional annotation analysis confirmed what is, in the most cases,
well described in the literature: Gram-negative bacteria with high lipopolysaccharide
and Bacteroides and Escherichia coli with genes related to oxygen. With respect
to short-chain fatty acids (SCFAs), most of the genes were found in Clostridiaceae
(butyrate) and Lactobaciliaceae (acetate).
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Figure 9: Similarity in carbohydrate enzyme capacity per genera. The result divided
the most abundant genera found in the human gut microbiome into three clusters.
With the exception of Prevotella, the species in the clusters are related with the most
abundant species in the enterotype clusters. Species in cluster one are more similar
to each other in the use of carbohydrate enzymes than are those in clusters two and
three.
page 33 of 33
96 Results
Chapter 4
Conclusion
The understanding of how the human gut microbiome affects health has changed
during recent years. The MetaHIT project and the results of this thesis are partially
responsible for that change. The connection between the microbiome and disease
is not as direct as once thought — it is complex, and the microbiota may play
an indirect role in disease, probably through the loss of so-called ‘good’ bacteria.
Moreover, variation in the human gut microbiome cannot be explained by factors
such as food, genotype, nationality, or pathogenic bacteria. Thus, the idea that
so-called ‘bad’ bacteria cause disease is losing strength. Our results indicated that
diversity defines the human gut microbiome, and decreases in diversity resemble
the effects of dysbiosis. In particular, the innate immune system may play a more
influential role in intestinal homeostasis than previously perceived. The equilibrium
between the immune system and immunoregulatory bacteria appears to be a delicate
balance in which the loss of a specific species can lead to an overreaction of the innate
immune system. The mechanism through which the imbalance starts is unclear, but
once it begins, it can lead to strong inflammatory responses that may cause tissue
damage and disease.
This thesis accomplished three technical milestones. A Gut-Array was developed with
which to profile hundreds of DNA and RNA samples rapidly. The current version of
the array (version 6.0) includes 840,000 genes with five probes per gene, representing
more than 80% of all data from the 700 samples sequenced. This versatile tool can
be used to explore overall tendencies as well as to determine how one variable can
affect an ecosystem. The array provides a singular opportunity to profile the effects
of drugs or bacteria on the gut microbiome at the DNA and RNA levels. It may
also be used to test various industrial products or compounds in clinical testing.
The Gut-Array tool makes the analysis of high-throughput data affordable to small
laboratories, hospitals, and industry. Moreover, we generated a large amount of
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empirical data from the human gut microbiome for the first time in this thesis —
specifically, a profile of 350 RNA samples and 350 DNA samples using the Gut-Array.
The development of software to analyse metagenomic data was another important
part of this thesis. I created an R-package, MetaHIT-R, for rapid profiling of 16S
rRNA, DNA, and RNA data obtained through sequencing or array. This package
has many functions that transform data from basic information to biological infor-
mation, and all of the figures presented in the third article described above were
generated using the program. Biological annotation of the data is required to fully
utilise MetaHIT-R. Therefore, I created a pipeline to annotate more than 4 million
bacterial genes with taxonomy and functional information. For taxonomy annota-
tion, I extracted the exact taxonomy or used prediction models in cases in which
exact taxonomy was unknown. For functional annotation, the genes were annotated
using the COG, eggNOG, KEGG, CAZy, and Pfam databases. This infrastructure
can be easily applied to other metagenomic projects.
The scientific results can be found in the three published articles outlined above. The
articles represent the evolution of our view of the gut microbiome. The first article
provided us with the highest number of empirical metagenome sequence data from
the human gut microbiome. The species network by co-abundance demonstrated
an unexpected result, showing that Bacteroides species have few species degrees and
form a separated network, whereas Firmicutes species are more connected with other
species. Moreover, the overall abundance of those species was very different. Whereas
Firmicutes had a very low median abundance, most of the Bacteroidetes had high
abundance. We wondered whether the species abundance and its species degrees
were connected, suggesting different levels of independence which could explain their
role in the gut. The third article is an extension of our results from the first paper
in which we applied an ecological approach and explored dysbiosis to explain the
dynamic of the gut microbiome.
The second article marks the beginning of our new perspective on the microbiome and
disease. It demonstrates three major compositions in the human gut microbiome but
cannot explain them. The publication of the paper had a major impact because it did
not offer biomarkers to explain the microbiome–diseases link. This move away from
a search for biomarkers represents a new approach to understanding the microbiome.
The introduction of these ideas was followed by many reviews (including insights and
perspective articles). One of these reviews indicates that the way to understand the
microbiome is through the use of ecology. As I worked on this project, I began to see
many features that were incompatible with the conclusions of other researchers. For
instance, to design a microarray capable of evaluating any human gut microbiome,
I needed to find genes that were common among many individuals. Although the
gene catalogue reported 3.3 million genes, my analysis indicated that more than
2 million genes were rare, suggesting that the real number of genes in the human
gut microbiome is lower than what has been suggested. With 700 thousand genes,
the microarray is capable of profiling nearly the full range of the gut microbiome,
as the number of genes in samples varies from approximately 200,000 to 1 million.
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Moreover, I observed that most of the rare genes were present in samples with high
Firmicutes abundance, and most of them had no taxonomy classification. Early in
this research, the results were already indicating characteristics of the human gut
microbiome that are explored in more detail in the third article.
The third article describes in detail the characteristics of the gut microbiome dynamic
using an ecological approach. We showed that 90% of the relative abundance of the
human gut microbiome consists of two phyla (Bacteroidetes and Firmicutes). These
two phyla have the highest variance in all datasets, thus demonstrating their impor-
tance in the gut of both healthy and unhealthy individuals. Moreover, we found that
the B/F ratio forms a strong pattern that defines the composition of the human gut
microbiome. This trend was associated with diversity and led to biological changes in
the ecosystem. Thus, we concluded that a high abundance of Firmicutes is associated
with high diversity, whereas a high abundance of Bacteroidetes is associated with low
diversity. These observations are important, because the ecosystem may be exam-
ined by measuring the overall abundance of just one phylum. In clinical tests, an
overabundance of Bacteroidetes signifies unhealthy gut microbiota, and monitoring
Bacteroidetes abundance in patients could alert doctors before severe disease occurs.
We also propose that high-diversity samples are healthier than low-diversity sam-
ples. This classification supports previous observations that high-diversity samples
are healthy [58, 60, 68, 114]. This classification may be the first step in under-
standing how the microbiota influences inflammatory disease. Thereofore, The first
important result is the association of B/F ratio with diversity. Many studies to date
have demonstrated the composition of these two phyla with various interpretations,
and many other studies have demonstrated differences in diversity among healthy
and unhealthy individuals. We demonstrated for the first time the strong associ-
ation of diversity and shifts in gut microbiome composition. The species network
demonstrates some interesting characteristics which have never been reported, such
as species degrees, and describes which species interact more frequently with species
from other taxonomy groups. However, the two most important results of the third
article are related to the data obtained through delta diversity calculations and de-
terminations of variance among diversity. Delta diversity clearly demonstrated that
the human gut microbiome is high diversity and composed of all possible species,
and low-diversity samples are subgroups (nested). The same idea is often used for
bioconservation studies to measure the impact of disturbances in an ecosystem. The
variance showed that as an ecosystem loses diversity, samples become less similar to
one another, which offered for the first time a possible explanation for the lack of
biomarkers in the human gut microbiome.
Because the network suggested various levels of independency among species, I also
explored that issue. Using genome size and functional analysis, I separated the two
major phyla in the gut microbiome as generalists and specialists; most of the Fir-
micutes were specialists, and most of the Bacteroidetes were generalists. This view
is completely different from previous perspectives of the gut microbiome and does
not relay on so-called ‘good’ or ‘bad’ bacteria. The idea of stages is also becoming
more common in the scientific community. I demonstrated that the gut microbiome
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enterotypes have different diversity levels and are nested. Therefore, the enterotypes
are in fact ‘Enterostages’, losing diversity when perturbation occurs in the micro-
biome. Putting the results of the third paper in context with studies that have been
published thus far, I generated the first model that explains the dynamics of the gut
microbiome and how they can be restored to the original stage after perturbation (i.e.
resilience and ‘Enterostages’). Moreover, I offered an explanation to integrate the
many independent conclusions of other studies that addressed diet (obese patients
have high abundance of Firmicutes), enterotype, transmissible dysbiosis, disease-
related microbiome shifts, lack of biomarkers, probiotics, and immunity.
To conclude, I believe the co-evolution of the human gut microbiome and its host is
the most important factor in shaping its function. The two major roles of the gut
microbiome are to protect the host against alien species and provide energy from
food. Therefore, the shifts we observed are not related to ‘good’ or ‘bad’ bacteria
or biomarkers but are an evolutionary response of the microbiome to disturbances.
Because the gut is an anaerobic environment colonised by indigenous species (species
that co-evolved with the host), aerobic pathogenic species are unlikely to invade
and colonise the gut, as the lack of oxygen is a major barrier. However, anaerobic
pathogenic species can invade and cause disease. The first host response is to activate
the innate immune system, and one of the characteristics is to induce the production
of ROS. This reaction eliminates anaerobic pathogen species, thereby eliminating
the disease. However, if the gut were invaded by facultative pathogenic species
— facultative species that can outcompete anaerobic species — it would have an
advantage when the innate immune system activated ROS, removing the competition
and increasing energy capacity, thus increasing its fitness. One feature that has been
demonstrated before is the increase of bacterial concentration in the gut when the
shift in composition occurs at the same time that diversity decreases. This mechanism
may be one that developed in the microbiome to outcompete pathogenic bacteria in
the gut, especially facultative species. Having bacteria that are more self-sustaining
and have a high range of functional capacity is important when the human gut
microbiome is under stress.
My results from the third paper suggest that Bacteroides have this characteristics
and may play a protective role in the gut when the ecosystem is under stress. Spe-
cialists, mostly Firmicutes, have an energetic role when the system is under optimal
conditions. However, the species network also showed that generalists are not re-
stricted to Bacteroides. We also found some Firmicutes species with high abundance
and low species degrees. Coincidently, those species are also aerotolerant/facultative,
like some species from the Bacilli class. Specialists are not restricted to Firmicutes.
The results in the third paper demonstrated that some Actinobacteria species could
also be considered specialists and disappear at the first sign of ecosystem disturbance.
The model may also explain the role of probiotics in diseases and gut microbiome
composition. As was discussed earlier, some species (specialists) do not survive when
the ecosystem is under pressure. Thus, the use of probiotic specialists is likely to have
no effect if the ecosystem is under stress. Coincidentally, many probiotic organisms
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are aerotolerant/facultative and capable of growing independently of other species.
This capability is found in generalists in the gut microbiome, suggesting a role for
some probiotics when the system is disturbed. The capacity to grow bacteria in the
laboratory suggests a level of independence. One of the first bacteria to be isolated
and easily cultivated in the laboratory was E. coli, which has become a ‘model’
organism because it is so easy to work with in that setting. Its level of independence
and its facultative capacity to grow with or without oxygen also suggest a role during
ecosystem stress. High levels of E. coli have been reported in many studies, as
mentioned in the background section. In our model, E. coli may represent the last
stand of the gut microbiome against facultative pathogenic species. However, the
same co-evolutionary system, which was designed to protect the host, can also be
used against it, indicating a gap in the microbiome–host relationship. An E. coli
organism with a pathogenic island has a strong fitness advantage because of the
dynamic of the gut microbiome and the immune system. The same tools developed
by indigenous E. coli to avoid an immune response can be used by alien E. coli
to infect a host, making avoidance of infection impossible for the host microbiome.
Coincidently or not, many cases of serious illness originating in the human gut have
been related to specific strains of E. coli.
The results of the third article demonstrate that the human gut microbiome has
characteristics of resilience. The definition of resilience in ecology is the capacity
of the ecosystem to experience disturbance and recover to its original stage. Using
the species network, species degree, and functional analysis, we demonstrated that
some species (generalists) have an important role when the system is under pressure.
However, how does it recover? Our model offers an explanation. Many specialist
species, such as Clostridium, produce endospores, which guarantee that they will
survive as spores and return when the ecosystem is more favourable for their growth.
This strategy is used widely in nature by a large number of species in addition to other
survival strategies when an environment is unfavourable. Another characteristic of
the gut microbiome is the large tail in its distribution, which indicates that even
though it may be composed of many species, few species are actually highly abundant,
and the majority have low abundance. Survival with very low abundance may be
another bacterial strategy for surviving an unfavourable environment.
Bacterial filamentation is yet another interesting survival strategy that has been
well documented but not well understood. Bacteria such as E. coli can change
shape under stress, forming long cells up to 50 times its normal size. An interesting
discussion about how the morphologies of the bacteria change under stress has been
published [121]. As has been discussed before, an increase in Gram-negative bacteria
is observed when immune response increases, and Gram-negative bacteria contain
bacterial LPS recognised by the immune system. Escherichia coli do not filament if
Toll-like receptor 4 is knocked out [122], suggesting that the receptor is responsible for
activating the change in the bacteria morphology. This change in morphology helps
bacteria survive the immune response specifically by evading Europhile phagocytes
[122]. This phenomenon suggests a link between the gut microbiome and immune
response.
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The profiling of DNA abundance in the human gut microbiome was an important step
toward a better understanding of the distribution of the microbiome in the gut and
the dynamics of the gut microbiome. The Gut-Array also allowed us to profile RNA
expression. Now that we know ‘who is there’, we want to know ‘what are they doing’.
However, RNA analysis in an environmental system is complex. By using DNA, we
analysed two main variables: the species present in a sample and the abundance of
those species. DNA is considered very stable over time, even when the diet of an
individual changes. However, RNA is not expected to be stable, and bacteria likely
express distinct genes at different points in time. The first attempt to characterise
the functional human gut microbiota occurred in 2011, when María Gosalbes and
co-workers [123] used messenger RNA sequencing data from 10 healthy individuals
to show that the composition of the active microbiota is more uniform than the
taxonomic composition, and our results confirmed this observation. RNA analyses
revealed that the variance of Firmicutes was greater than that of Bacteroidetes.
This result differs from that in DNA and reflects the importance of Firmicutes in
the functional gut microbiome. Analysis of the most abundant species expressed in
each sample reveals a very interesting trend. The expression of species seems to be
divided into three groups (similar to the division in DNA), in which the first group is
dominated by Clostridium species and is characterised by high diversity. The second
group expresses mostly Eubacterium species and has intermediate diversity. The
third group is composed of Ruminococcus species with low diversity.
These three groups of highly expressed species could be interpreted as the enterostages
of RNA in the gut microbiome. Surprisingly, Bacteroidetes are not the most ex-
pressed species, although they are the most abundant at the DNA level. The vari-
ance in the expression in our data is smaller than that in abundance, which reflects
the results of other studies. Thus, RNA may tell a different story than DNA does.
Whereas DNA results appear to be related to survival by allowing species to adapt
to a stressful environment, RNA results may be related to the expression of proteins
with important functions in the gut. Although DNA analysis did not reveal any
species-specific association with disease, RNA expression shows more promising re-
sults. Examination of the expression of phyla revealed that Firmicutes are positively
associated with TNF-α, which is involved in the regulation of immune cells. Dereg-
ulation of TNF-α production has been implicated in a variety of human diseases,
including Alzheimer’s disease [124], cancer [125], and IBD [126]. Thus, this result
supports the theory of dysbiosis and immune-response observed for the DNA data.
Using genus expression, I observed that Clostridium, Blautia, and Oribacterium are
positively associated with lean fat, whereas Dorea, Ruminococcus, and Coprococcus
are positively associated with fat and body mass index. Moreover, the same trend
was observed using higher taxonomic levels such as order. Specifically, Clostridiales
was the main order displaying a positive association with obesity indicators, which
agrees with results reported by Ruth Ley [48]. This preview of RNA results supports
the DNA results found in the third paper in this thesis but adds another layer of
complexity, improving our view of the relationship between the microbiome and its
host.
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Combining all of the results presented in this thesis shows how the scientific view of
the gut microbiome has changed. This view is becoming more common and accepted
by the scientific community, and a large number of related reviews and original
studies have been published in the field as of 2012. It is important to remember that
the view of the gut microbiome is always limited by the technology and information
available at the time of a study. Therefore, I expect to see this view, including the
models I created, to change and improve within the next few years. I believe that
the overall observations in the model will stay, as they are based on results from
many studies. Detailed information about precisely what is happening in each stage
is likely to emerge soon as well.
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